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Abstract
During a square-wave increase in work rate (WR) there is an immediate and abrupt 
increase in energy (ATP) demand. The associated phase II kinetics of pulmonary 
oxygen uptake (Fo^) are now known to reflect those of muscle oxidative 
phosphorylation (QO 2  ). The control of VO2  kinetics remains a topic of intense debate. 
One of the candidate mechanisms is feedback control via high-energy phosphate status, 
which is supported by a close matching of the response kinetics o f phosphocreatine 
(PCr) breakdown and FO2  increase following exercise onset. Above the lactate 
threshold (9l) FO2  kinetics become more complex, with a delayed slow component 
which induces a greater O2 cost which, as work rates exceed the critical power (CP), 
places FO2  on a trajectory for maximum (or peak) FO2 . The mechanism(s) responsible 
for the FO2  slow component remain conjectural. One recently proposed mechanism 
might involves mitochondrial uncoupling protein expression.
The present study examined phase II FO2  kinetics during moderate and very heavy- 
intensity cycling exercise with respect to muscle creatine kinase (CK), the enzyme 
involved in PCr breakdown, whose activity may be important in dictating recruitment of 
muscle QO2 . Second, as mitochondrial uncoupling protein expression (UCP-2 and 
UCP-3) has been implicated in the compromised oxidative efficiency of the Fo, slow 
component, these kinetics were examined with respect to the degree o f UCP expression. 
Finally, as FO2  kinetics above critical power (CP) are poorly characterised, repeats at
two exhausting WRs were used to appropriately characterise VO2  kinetics, placing 
emphasis on the degree of inter-subject variability, and to examine potential 
relationships of variability in kinetic parameters with CK activity, UCP expression and 
aerobic fitness.
In six subjects, gas exchange was measured breath-by-breath and Vo2  kinetics were 
modelled using commercially available software. Muscle biopsy samples from the 
resting quadriceps femoris muscle were analysed for CK activity (gel electrophoresis 
and spectrophotometry). UCP niRNA was measured (reverse-polymerase chain 
reaction) and expressed relative to protein content ((3-actin). Each subject performed an 
exhausting ramp exercise test for estimation of the lactate tlireshold (0 l ). Six square- 
wave exercise tests to 90% of 0 l were then performed on two separate days. The high- 
intensity power-duration relationship, determined firom three to five fatiguing square- 
wave tests performed on different days, was used to estimate (a) CP (the asymptotic 
power) and (b) the WRs required to elicit a target duration for fatigue of 12 and 6 
minutes.
CK activity ranged from 2.38 to 3.11 absorbance.min'^ and th  VO2  for moderate- 
intensity exercise ranged from 16 to 25s. A significant positive relationship was found 
between CK activity and xn during moderate intensity exercise (p<0.01). For very 
heavy-intensity exercise (supra-CP), appreciable inter-subject variability was evident 
for the VO2  kinetics: (a) th  ranged firom 15-46s and showed a non-significant trend 
towards a positive association with CK activity; (b) the slow component amplitude (Age)
11
ranged from 0.47 to 1.02 l.m in '\ but this variability did not significantly associate with 
UCP expression, which ranged from 2.2 to 5.4 O.D for UCP-2 and 1.2 to 3.0 O.D. for 
UCP-3; and (c) variability in the kinetic parameters was not significantly correlated 
with markers of aerobic fitness.
This study has shown that the phase II Vo^  time constant related to CK activity, 
although a cause-and-effect relationship could not be determined. Furthermore, the 
amplitude of the Vo^  slow component was not related to UCP inRNA expression 
(contrary to a recent report) and therefore elucidation of the mechanism causing the 
slow component awaits further investigation.
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CHAPTER 1
INTRODUCTION
1.1 ENERGY PRODUCTION DURING EXERCISE
The energy required for daily living and for increases in metabolic demand, such as with 
exercise, is supplied through the potential energy of the high-energy phosphate bonds in 
adenosine triphosphate (ATP). As the storage of ATP within the muscle is minimal (~5 
mM wet/kg) (Hultman, 1967), ATP re-synthesis is provided through the anaerobic alactic, 
anaerobic lactic and aerobic energy producing systems. These processes of energy transfer 
in exercise or bioenergetics are detailed in textbooks of exercise physiology (McArdle et 
al., 1991; Wasseiman et al., 1987; Brooks et al., 2000). This section briefly reviews energy 
production during exercise.
The anaerobic alactic systems involve the breakdown of stored muscle phosphocreatine 
(PCr) which then donates a high-energy phosphate to adenosine diphosphate (ADP) for 
ATP and creatine (Cr) production, as shown in equation 1.1:
PCr + ADP + H^f-f Cr + ATP [1.1]
The muscle can store approximately 15 mM wet/kg of PCr (Hultman et al., 1967) (250-400 
mg total), therefore providing an extremely rapid but limited supply of ATP (~6 s for “all 
out” exercise) (Pernow and Karlson, 1971).
The anaerobic lactic system produces ATP through the oxidation of carbohydrates by way 
of glycolysis and lactate and H’*' production (Gollnick and Hermansen, 1973). Glycolysis 
involves a series of chemical reactions which breakdown glucose (or glycogen) to the end- 
product pyruvate acid, and then pyruvate is converted to lactate as shown by equation 1 .2 . 
This yields a low ATP in comparison to the capacity of the aerobic system, but at a more 
rapid rate (Alpert, 1965).
Glucose + 2Pi + 2ADP pyi'uvate ^  lactate + 2 H2O + 2ATP [1.2]
where P, is inorganic phosphate, ADP is adenosine diphosphate and ATP is adenosine 
triphophate.
The aerobic system utilises the energy available through the oxidation of carbohydrates, 
fats and to a much lesser degree, protein. As described above, glucose or glycogen is 
broken down through glycolysis resulting in the production of pyruvate. As pyruvate is 
then converted to acetyl coenzyme A (acetyl CoA), it is available for the Kiebs cycle within 
the mitochondria. Fats undergo P-oxidation leading to the production of acetyl CoA.
Proteins, depending on the specific amino acids, enter the energy production system at the 
level of pyruvate, acetyl CoA or directly within the Krebs cycle. Acetyl CoA undergoes 
further chemical reactions within the Krebs cycle, which most importantly lead to the 
generation of nicotinamide adenine dinucleotide (NADH) and, to a lesser degree, flavin 
adenine dinucleotide (FADH2). These reduced substrates are then available to the electron 
transport system and go through a series of redox reactions, with O2 being the final election 
acceptor. The energy from these electron transfers pumps protons across the mitochondrial 
membrane and the electrical gradient then harnesses the energy required for ATP re­
synthesis. The O2 taken up per ATP produced is higher for fat than carbohydrate, although 
the CO2 production per O2 is less for fat than carbohydrate metabolism (e.g. Brooks et al.,
2000) as shown by equations 1.3 and 1.4, respectively:
C 16H32O2 + 2302 ^  I 6 CO2 + I 5 H2O +130ATP [1.3]
C6H 12O6 + 6 Ü6 ^  6 CO2 + 6 H2O +36/37ATP [1.4]
During rest and in the steady state of exercise, by definition the energy systems are in a 
state of equilibrium. It is during the transition from one work rate to another that the 
steady-state equilibrium is disrupted. With an instantaneous change from either rest or a 
low work rate to a higher work rate, the increased metabolic demands are met by the energy 
production systems working in combination. Ideally, during sustained exercise, the gieater 
the aerobic contribution to energy production the better; i.e. most efficient mode of ATP 
production. This is because there is a limited supply of stored PCr and less fatigue will
ensue if the product of lactate (and therefore H^) from the anaerobic lactic system is 
minimised. Therefore, routes of ATP re-synthesis determine the intensity and duration of 
exercise, and the rate of increase in oxygen utilisation at the onset of exercise is also 
important in relation to the requirement imposed on the other energy systems.
1.2 MUSCLE OXYGEN CONSUMPTION
As O2 is the final electron acceptor for aerobic production of ATP, during exercise muscle 
O2 uptake ( gOj ) provides an indication of the rate of aerobic production of ATP. QO  ^ is 
given by the Pick equation 1.5:
QO2  -  Q.(Ca02-Cv02) [1.5]
where Q is muscle blood flow, Ca0 2  is arterial oxygen content and CVO2 is muscle venous 
oxygen content.
In humans, measurements of Q can be made at the feed artery of the exercising muscle 
group indirectly using Doppler ultrasound (Radegren and Saltin, 1998) and directly using 
thermodilution techniques (Andersen and Saltin, 1985). The O2 content in the femoral 
artery and vein of the exercising muscle group can be determined from blood samples by 
catheterisation, but this approach is highly invasive. In addition, the combination of the 
above measurements does not provide an exact reflection of the QO  ^ for the exercising
portions of the muscle (or active motor units). This is because: i) the blood flow and the 
venous O2 content measures also include non-exercising muscle and skin; ii) within the 
exercising muscle group Q : QO2  inhomogeneities exist (Richardson et al., 2001); and, iii) 
there is a temporal delay between QO2  and the sample site for CVO2 . A useful expedient 
in humans that circumvents these approaches is to measure pulmonary oxygen uptake 
( VO2  ), which has been argued to provide a proxy for QO2 . For example, Barstow et al. 
(1990) have modelled the and QO2 inter-relationships during moderate exercise and 
concluded that r  VO2  is within 10% of r  QO2 . In addition, Grassi et al. (1996) have shown 
a similarity in 7  VO2 and r  QO2 , in humans when QO2  is measured in humans via limb 
blood flow measurement and the arteriovenous O2 difference across the exercising muscle 
group.
Thus, not only in the steady state but also in the transient, the exercise-induced increase in 
muscle oxygen uptake (AQO^) is reflected, with essentially no loss of dynamic fidelity, in 
a corresponding increase in pulmonary oxygen uptake (AFO^). This is provided no 
additional movements of non-exercising muscles are incorporated (i.e. of the upper body). 
The pulmonary VO2  response to exercise will also include the oxygen cost of respiratory 
muscles and the heart, although these have been argued to be a minimal contribution in 
healthy subjects even at maximal-intensity exercise (Poole et al., 1994). In addition, it 
should be noted that an anatomical muscle-to-lung transit delay exists, such that blood from 
the exercising muscle does not appear instantaneously in the pulmonary capillaries (Krogh
and Linhard 1913; Whipp et al., 1982). Thus, the response to exercise is reflected in 
the AFc>2 after an appropriate time delay (see section 1.5 for further discussion).
Over the last two decades or so, the development of breath-by-breath VO2  measurements 
using rapidly-responding gas concentration and volume transducers has resulted in a 
substantially improved resolution of response dynamics (Beaver et al., 1973 and 1981). 
Also, by performing multiple repeats, the signal-to-noise ratio can be appreciably increased 
(Lamarra, 1987).
1.3 EXERCISE INTENSITY DOMAINS
The characteristics of the temporal response profile of VO2  are dependent on the exercise 
intensity. This is well illustrated for a square-wave change in work rate (Whipp and 
Wasserman, 1972; Whipp and Mahler, 1980; Paterson and Whipp, 1991; Ozyener et al.
2001), Pulmonary gas exchange depends critically on whether ATP is re-synthesised solely 
from aerobic means or whether anaerobic lactate-producing mechanisms are also activated. 
It is useful therefore, to define exercise intensity in terms of arterial lactate concentration 
[La] (Whipp and Wasserman, 1972). There are two important functional demarcations that 
can be considered in this regard: the lactate threshold ( 0 l )  and the critical power (CP) [or 
fatigue threshold (Op)].
0LÎS a threshold VO2  above which there is a sustained increase in arterial [La]. It has been 
argued by Whipp (1994) that most of the evidence to date indicates anaerobiosis may be the 
most likely mechanism for the increased [La]. With a lack of O2 supply, a limitation in the 
rate at which the pyiuvate produced from glycolysis can be utilised by the Krebs cycle 
would occur and therefore the pyruvate would be converted to La. This suggestion is 
supported by the evidence that, when inspiring a hyperoxic mixture during progressive 
exercise, the onset of [La] increase was delayed, and similarly, with hypoxia, 0 l was 
reduced (e.g. Yoshida et ah, 1987). Another suggested hypothesis is that there is an 
increase in the recruitment of type II fibres at the onset of 0p. As type II fibres have less 
mitochondria, their oxidative potential is lower (Holloszy, 1967), and therefore their 
recruitment may result in an increased lactate production. Although the mechanism 
responsible for 0 l remains to be elucidated, it is clear that there is in an increase in [La]. 
This can be estimated non-invasively through gas exchange measurements as an increase in 
pulmonary carbon dioxide output (FCO^) relative to VO2  (V-slope) as shown in Figure 1.1 
(Davis, 1985; Beaver et ah, 1986; Whipp et ah, 1986).
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Figure 1.1 Non-invasive estimation of the lactate threshold (AT) using the V-slope 
technique (Beaver et al., 1986). Best-fit lines (Si & S2) are plotted through the sub- 
and supra -0 l(A T) data respectively, 0l(A T) determined as the point of intersection 
of the two lines. Adapted from (Beaver et al., 1986).
This increased VCO^  is due to HCO3 " buffering a proportion of the associated with the 
lactate that is produced in the conversion from pyruvate (see section 2.4.1 for details 
regarding identification of 0l ).
CP is the work rate above which the tolerable duration (t) of constant-load exercise 
decreases systematically with increased work rate (Monod and Scherrer, 1965; Moritani et 
al., 1981; Poole et al., 1988). The power asymptote of the hyperbolic power-duration 
relationship (P-t), or the y-intercept of its P-l/t linear transform, defines this work rate
(Poole et al., 1988; Hill, 1993) (see equation 1.6). In addition, the curvature constant of the 
P-t hyperbola, or the slope of the P-l/t relationship, represents a constant amount of work 
(W’) that can be performed above CP (Moritani et al., 1981; Poole et al., 1988; Fukuba and 
Whipp, 1999) (see equation 1.7):
P=W’.(l/t)+ CP 
W ’=(P-CP).t
[1.6]
[1.7]
An example of the P-t curve and the corresponding P-l/t relationship is shown in Figure 
1.2 .
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Figure 1.2. The power-duration relationship for x constant-load exercise bouts, (a) Shows 
the hyperbolic P-t relationship where the asymptote of the power axis is CP and the 
curvature constant is W’. (b) Shows the P-l/t relationship, where the intercept on the power 
axis is CP and the slope of the line is W’ (adapted from Poole et al., 1988).
The mechanism of CP remains to be elucidated. However, it has been suggested CP 
coincides with the work rate equivalent to the maximal lactate steady state (MLSS), 
wherein there is an elevation in [La] due to production, but the level remains stable as the 
production is balanced by the rate of clearance (e.g. Poole et al., 1988). However, recently 
Pringle et al. (2002) have suggested that CP determined from the power-duration cmwe 
occurred at a WR ~6 % higher than the WR corresponding to MLSS (defined as when a less 
than Immol.r^ increase in [La] occurred across the last 20 min of exercise). Therefore, 
further research is required to elucidate the association between CP and MLSS as the 
mechanism of CP.
W ’ has been referred to as the ‘anaerobic work capacity’ and it has been suggested it is 
related to finite energy stores of high-energy phosphates, glycogen stores (for anaerobic 
glycolysis) and O2 stores (Monod and Scherrer, 1965; Moritani et al, 1981; Hill 1993; 
Miura et al., 2002). More recently, it has also been suggested W’ could be associated with 
the build up of fatiguing intramuscular metabolites (H*^  and PJ reaching critical levels 
(Coates et al., 2003).
0 L expressed as a percent of VO2  peak is variable between individuals (ranging by as much as
40-80%) (Davis et al., 1976; Reinhard et al., 1979). Likewise, CP when expressed as a 
percentage of WR peak is variable across subjects (Whipp and Ward, 1992). Thus, as will 
be discussed later, the WR normalisation to determine a similar relative stress for different
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individuals cannot be done simply relative to VO2  peak, as all fatiguing WRs at and above CP 
elicit a VO2 essentially equal to VO2  peak (see section 4.3). Therefore, expressing the WR as 
a percentage of the VO2  peak (or maximum heart rate, maximum work rate, or METs, which 
represent multiples of the resting metabolic rate, where 1 MET is 3.5 ml.kg"\min'^) does 
not provide an appropriate method to define the exercise intensity. This is because it would 
not be known a priori (Whipp and Ward, 1992; Whipp et al., 2002) if the work rates 
prescribed would be above or below an individuaTs Ol and CP.
As these thresholds are closely associated (Pringle et al., 2002) with lactate status, the 
partitioning of the different exercise intensities has been based on arterial [La] (Wasserman 
et al., 1967). Moderate-intensity exercise is defined as those WRs that lie below Ol , thus 
either no increase in [La] occurs or [La] increases initially but then returns to baseline 
values. Heavy-intensity exercise is defined as work rates that are above 0 l , and thus [La] 
increases initially but over time reaches a steady state level, or may even decline slightly. 
Very heavy exercise refers to work rates that are above CP, with [La] increasing throughout 
the work bout to the point of fatigue (Whipp and Ozyener, 1998; Ozyener et al., 2001) (see 
Figure 1.3).
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Figure 1.3. Assignment of exercise intensity based on the profiles of arterial [La] 
during constant-load exercise at different work rates. Adapted from Wasseiman et al. 
(1967).
The VO2  response within each of the exercise domains will be discussed in detail below. 
However, briefly, it can be see in Figure 1.4 that, within the moderate intensity domain VO2  
increases exponentially to attain a steady state; in the heavy domain VO2  continues to 
increase and eventually stabilises; in the very heavy intensity domain, VO2  continually 
increases and is truncated at VO2  peak; and, in addition, a severe intensity domain is defined, 
which occurs when the Vo 2 requirement is greater than VO2 peak and therefore VO2 quickly 
impacts on peak, resulting in a very short tolerable duration (Whipp and Ozyener, 1998; 
Ozyener et al. 2001)
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Figure 1.4. Illustration of the dependence of VO2  kinetics on exercise intensity 
domain. Thick solid lines represent the VO2  response, and dashed lines signify the 
intensity domain boundaries of lactate threshold ( 0 l) ,  critical power (CP) and 
peak (luFo^). Shaded areas reflect the additional above that predicted for 
the given work rate based on < 0 l equations. From Whipp & Ozyener (1998).
1.4 TEMPORAL DOMAINS FOR Vo^
1.4.1 Moderate intensity exercise
Phase I
This period of time is due to the muscle-to-lung transit delay and lasts approximately 15- 
20s (Cummin et al., 1986; Casaburi et al., 1989). The blood returning from the muscle to
13
the pulmonary circulation still reflects the composition of the blood in the muscle prior to 
or very early in the transient, and thus the arterio-mixed venous O2 content difference 
(CaOz-CvOz) will not yet be increased (i.e. the blood reflecting an increased oxygen 
extraction with exercise has not yet arrived at the lungs) (Krogh and Lindhard, 1913; 
Whipp et al., 1982). However, an increase in VO^ is apparent during this period due to the 
instantaneous increase in Q , and therefore pulmonary blood flow, when the work rate is 
increased (Cummin et al., 1986). This initial phase is therefore termed the ‘cardiodynamic 
phase’ (Krogh and Lindhard, 1913; Whipp et al., 1982). A schematic of the phase I 
response is shown in Figure 1.5 (page 17).
Phase II
Phase II follows the cardiodynamic phase. The response in phase II represents the 
dominant component of the non steady-state response and has been argued to reflect QO^, 
as noted earlier. The Vo ^  response increases mono-exponentially toward the steady state 
according to the equation:
LVO2  (t) = AFOj (ss) • [ 1 .8 ]
where A VO2  (t) is the VO2  increment at time t, A VO2  (ss) is the steady state VO2  increment 
above baseline, r  is the time constant (i.e. the time to reach 63% of the steady-state Fo^ ) 
and Ô is the delay term reflecting the influence of the muscle-to-lung transit time
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(Linnarsson, 1974; Casaburi et al., 1978; Whipp et al., 1982; Miyamoto et al., 1982; 
Barstow et al., 1994; Hughson and Kowalchuk, 1995). A schematic of the phase II 
response is shown in Figure 1.5 (page 17).
Both the amplitude of the steady-state response {AVO2  (ss)) and the phase II time response 
(tii) of the increase are of much importance as they provide an indication of the amount of 
energy not supplied through oxidative phosphorylation, i.e. the ‘oxygen deficit’ (Oidef) 
(Whipp et ah, 1982; Whipp and Ward, 1992). The equation for 0 2 def is:
Ozdef.^ Tii*A VO2  (ss) [1.9]
For a given work rate, AVO2  (ss) is fairly constant among individuals (Hansen et al., 1987). 
The more significant component affecting the magnitude of the O2 deficit is Tn, as it can 
vary appreciably among individuals, with typical Tn values for young, healthy subjects of 
25-35s (Whipp et ah, 1982, 2002). From cross-sectional data, Tn is longer in subjects with 
lower cardiorespiratory fitness (Hickson et ah, 1978), although Tn as a function of Vo^ peak 
has also been shown to vary widely in the normal population (Whipp et ah, 2002). t h is 
greater in older individuals (Babcock et ah, 1994) and in cases of various chronic diseases 
(Sietsema, 1992; Hansen et ah, 1987; Nery et ah, 1982). From longitudinal studies, Tn has 
been shown to be increased with age (Bell et ah, 2001a) and decreased with training (or 
likewise increased with de-training) (e.g. Phillips et ah, 1995).
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To indicate whether the process involved in determining Tn is a single rate-limiting step, a 
control systems perspective follows. In terms of control system theory, it was originally 
thought that Vo^  kinetics conformed to a dynamically linear system within the moderate- 
intensity domain (Whipp, 1971; Whipp and Ward, 1990); that is, similar t\\ values would 
result for any change in work rate (e.g. Fujihara et al., 1973a). Additionally, there would be 
“on- o ff’symmetry of the time course of the phase II on-transient, and indeed the off- 
transient does appear to be similar to the on transient th (Linnarsson, 1974; Whipp et al., 
1982; Griffiths et al., 1986;Paterson and Whipp, 1991; Ozyener et al., 2001). Recently 
Rossiter et al. (1999, 2002b) have shown symmetry between the on- and off-transients for 
both VO2  and [PCr] for the moderate intensity domain.
This is consistent with the control system following first-order principles. Similarly, the 
principle of superposition would be expected to apply (Barstow et al., 1994; Rossiter et al.,
2002), with estimates of r  being unaffected by the particular WR forcing function being 
used. Indeed, investigations have variously used not only square-wave WR forcing (see 
above), but also ramps, (e.g., Hughson et al., 1986; Babcock et al., 1992; Niizeki et al., 
1995), impulses (e.g. Miyamoto et al., 1983; Hughson et al., 1988), sinusoids (e.g. Casaburi 
et al., 1977; Miyamoto et al., 1983, 1992; Cunningham et al., 1993) and pseudo-random 
binary sequence (PRBS) (e.g. Hughson et al., 1990, 1991; Essfeld et al., 1987; Edwards et 
al., 2001). However, arguing against a dynamically linear VO2  kinetics in moderate 
exercise, Hughson and Morrisey (1982) and more recently Brittain et al. (2001) and 
Paterson et al. (2003), have demonstrated that xn can differ with WR, or the prior exercise
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condition. Tu was longer in the upper region (in transition from the lower region) versus 
lower region (in transition horn loadless exercise) of moderate-intensity exercise. In 
addition, Rossiter et al. (2002b) recently found that r  was significantly longer for the off- 
transient in the upper-moderate intensity region for both Vo^  and [PCr], although the 
reason for these differing results is unclear at present.
Phase III
The phase III Vo 2 response represents the sum of the phase I and phase II responses. For 
cycle ergometry, it has an amplitude (or ‘gain’), relative to work rate (AKO2 /AWR) o f - 1 0  
ml.min'^watf* (Hansen et ah, 1987). A schematic of the phase III response is shown in 
Figure 1.5.
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Figure 1.5. Illustration demonstrating the three phases of Vo2  kinetics for moderate 
intensity exercise. Zero seconds represents the onset of exercise.
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1.4.2 Heavy-Intensity Exercise
As for sub-^L WRs, a phase I VO2  is also evident for all intensities above 8^ .
However, the kinetics of the subsequent VO2  response become more complex because of 
the appearance of an additional component with delayed and slowly developing 
characteristics, termed the VO2  ‘slow component’ or ‘excess’ VO2  (Whipp, 1987). This 
additional component introduces non-linearity into the overall response. These system non- 
linearities therefore imply that WR forcing functions such as sinusoids and PRBS are not 
appropriate for > characterisations, as they results in “lumped” parameter values for the 
combined on off transition (Whipp and Ward, 1990).
Phase II
The phase II time constant (tn) for heavy-intensity exercise has been shown to be similar to 
that of moderate-intensity cycle ergometry (Barstow and Mole, 1991; Barstow et al., 1993; 
Ozyener et al., 2001; Paterson et al. 2003; Pringle et al., 2003) and treadmill running 
(Carter et al. 2002). However, it has also been shown that at WRs above Ol, t  n for cycling 
is marginally increased (-5 - 1 0 s) in contrast to work in the moderate-intensity domain for 
cycling (Paterson and Whipp, 1991; MacDonald et ah, 1997; Sheuermann et al, 1998; 
Koga et ah, 1999; Jones et ah, 2002).
Similar to most studies of moderate-intensity exercise, the on- and off-transient t\\ values in 
the heavy-intensity domain have been shown to demonstrate symmetry (Ozyener et ah, 
2001; Paterson and Whipp, 1991). The gain of the phase II response has been shown to be
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similar to that of moderate-intensity exercise (Paterson and Whipp, 1991; Barstow and 
Mole, 1991; Ozyener et al., 2001) as well as lower than that for moderate-intensity exercise 
(Jones et al., 2002; Pringle et al., 2003).
Slow component
In the heavy-intensity domain, the VO2  response is delayed in reaching a new steady state. 
Furthermore, VO2  increases to a value beyond that predicted by the A VO2  /AWR estimation 
for sub (therefore less efficient), to as much as 13 ml.min'\W'^ (Whipp, 1987; Ozyener 
et al., 2001). The excess VO2  component can stabilise, given sufficient time eg. 10-20 
minutes (Whipp and Mahler, 1980).
The amplitude of the slow component appears to be less in more fit individuals (Barstow et 
al., 1996), decreases with training (Carter et al., 2000) and increases with increases in work 
rate above 0l (Whipp and Mahler, 1980). In the heavy intensity domain, a loss of “on-off’ 
symmetiy occurs as the slow component is apparent for the on transient but not for the off- 
transient response (Ozyener et al., 2001; Paterson and Whipp, 1991).
An empirical and useful indicator of the VO2  slow component magnitude is the AFO  ^
between minute 3 and 6  of exercise (Roston et ah, 1987; Whipp, 1987; Casaburi et al., 
1987; Poole et al., 1991; Gerbino et al., 1996; Russell et al., 2002). This index makes no 
assumptions about underlying model structure.
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However, controversy exists regarding the appropriate kinetic characterisation of the VO2  
response of supra 6l exercise. Paterson and Whipp (1991) used a model that omitted the 
phase I component and fitted the subsequent 3 minutes of exercise with a single 
exponential:
AVO; (t) = AFOj (ss) • 20s<tA180s [ 1 .1 0 ]
where AVO2  (t) is the VO2  increment at time t, and AVO2  (ss) is the asymptotic VO2  
increment above baseline.
It has been demonstrated that the slow component is of delayed onset, beginning at 
approximately 90-160s following the exercise onset (Wliipp et ah, 1987; Paterson and 
Whipp, 1991; Barstow and Mole, 1991; Barstow et ah, 1994; Scheuermann et ah, 1998; 
Bell et ah, 2001a; Ozyener et ah, 2001). Some investigations have therefore used a two- 
component, double exponential (omitting phase I) to characterise the response 
(Barstow and Mole, 1991; Bearden and Moffat, 2000; Bell et ah 2001a; Ozyener et ah, 
2001):
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A VO, (t) = AVO, (ss) • + AVO, (sc) • [1.11]
for 20s < t[ < Ô2 ; Ô2 < t2 360s
where AVO2  (t) is the VO2  increment at time t, A VO2  (ss) is the asymptotic Vo2  increment 
above baseline, n  phase II time constant and ôiis the delay term reflecting the influence of 
the muscle-to-lung transit time, A VO2  (sc) is the projected steady state VO2  increment 
above A VO2  (ss), T2 is the slow component time constant and 6 2  is the delay term reflecting 
the onset of the slow component. A double exponential fit of the VO2  kinetics is shown in 
Figure 1.6.
On-transient VO2  slow component t  values obtained using the double exponential model 
have shown a range from 120-23Os (Barstow and Mole, 1991; Bearden and Moffat, 2000; 
Ozyener et al., 2001; Bell et al., 2001a). However, to date, there is little physiological 
justification for an exponential fit of the slow component, as the mechanism of the slow 
component remains to be identified (Bearden and Moffatt, 2001; Whipp et al., 2002).
Rossiter et al. (2001) have provided a criterion for discerning the onset of the slow 
component, without recourse to an exponential fit for the VO2 slow component. An 
iterative process is used in which the fitting window of phase II was lengthened until the 
‘goodness’ of the model fit deteriorated, indicating the onset of the slow component. This 
was indicated by a threshold in the summed square error value and visual inspection of the
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residual profile for a consistent deviation from zero. The amplitude of the VO2  slow 
component can be derived as the A VO2  between the asymptotic value for phase II and the 
end-exercise VO-,.
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Figure 1.6. Modelling of the VO2  on-transient kinetics to heavy intensity exercise, 
including the double-exponential fit and residuals.
1.4.3 Very heavy exercise
Phase II
Relatively little research on VO2  kinetics has been conducted within the very heavy 
intensity domain. However, it was shown by Ozyener et al. (2001) that r  for very heavy 
intensity exercise was similar to that during all other domains of exercise (all 32-34s in this 
study). In addition, it was shown that the off-transient Tn value after very heavy intensity
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exercise was 33 s, therefore indicating that within this exercise domain on-off symmetry 
prevails.
Slow Component
As very heavy exercise is above CP, the VO2  response continues to increase until VO2  peak 
is reached. Ozyener et al. (2001) showed that the VO2  slow component was apparent 
during both the on- and off-transient in this intensity domain. The on-transient response 
was modelled with the double exponential function with separate time delays for the two 
components, which resulted in a slow component r  of 163s. The off-transient response was 
also fit with a double exponential model but without a separate delay for the slow 
component, resulting in an off-transient slow component r  of 460s. Figure 1.7 shows the 
VO2  kinetics to very heavy-intensity exercise with a double exponential fit.
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Figure 1.7. Modelling of the VO2  on-ti’ansient kinetics to very heavy intensity exercise, 
including the double-exponential fit and residuals. * indicates fatigue point.
1.4.4 Severe exercise
Phase II
Ozyener et al. (2001) demonstrated that the on-transient r  (35s) was similar to that found 
during the other exercise intensity domains. However, in contrast to the other intensity 
domains, the gain of the phase II response was found to be significantly lower than other 
intensities due to the response reaching VO2  max prior to attaining (or even approximating) 
a steady state (Ozyener et ah, 2001). It was also demonstrated by Ozyener et al. (2001) that 
on-off symmetry existed with r  on=34s and t  off=35s.
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Slow Component
The exercise durations in this domain are typically so short that a VO2  slow component is 
not induced to any discernible extent (Ozyener et al., 2001). However, the off transient 
demonstrated a slow component r  value of 539s (Ozyener et al., 2001). Figure 1.8 shows 
the VO2  kinetics to severe-intensity exercise, fit with a monoexpontial model.
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Figure 1.8, Modelling of the VO2  on-transient kinetics to severe intensity exercise, 
including the mono-exponential fit and residuals. * indicates fatigue point.
1.5 CONTROL OF QO^  KINETICS
As discussed earlier (section 1.2), direct measurement of QO  ^ (especially in the non-steady 
state) is technically difficult. However, the temporal response profile of VO2  measured
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breath by breath at the mouth provides an acceptable surrogate. Recent research 
investigating the control of the phase II VO2  kinetics of the exercise on-transient has been 
focussed on three main, competing, hypotheses, namely:
( 1 ) an O2 delivery or diffusion limitation
(2 ) an intramuscular O2 utilisation limitation operating via feed forward control; (or)
(3) an intramuscular O2 utilisation limitation operating via feedback control.
Evidence to date suggests that the limiting factor may differ with different intensities, and 
therefore the intensity domains are treated separately.
1.5.1 Moderate intensity exercise
1.5.1.1 O2 delivery
1.5.1.1.1 Evidence for O2  delivery as a limitation
Studies from Hughson’s gi’oup have demonstrated that when a slowing of Q occurs there is 
a corresponding slowing of Vo2 . Hughson and Kowalchuk (1991) and Hughson and 
Smyth (1983) showed that, with a /3-blocker intervention (which impairs cardiac output and 
therefore, presumably, Q), slower VO2  kinetics were seen compared to control. 
Alterations in body position have also been used to alter (decrease) Q . With both supine 
knee-extension exercise (MacDonald et al., 1998) and forearm exercise above the heart 
(Hughson et al., 1996), VO2  kinetics were significantly slower. These studies, however.
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only demonstrated that a slowing of Q slowed , they do not provide convincing 
evidence that Q necessarily limits VO2  kinetics in the normal state.
1.5.1.1.2 Evidence against O2  delivery as a limitation
Williamson et al, (1996) demonstrated that when blood flow was reduced with lower body 
positive pressure during exercise there was no change in the VO2  kinetics. In addition, 
studies have shown that the on-transient kinetics of Q are faster than those of VO2  during 
cycling exercise (Grassi et al. 1996), knee extension exercise (MacDonald et al., 1998; Bell 
et al., 2001b), and forearm exercise (Hughson et al., 1996), possibly suggesting that the 
transient Q response to the working muscles is sufficient. However, a recent study has 
shown evidence of blood flow heterogeneity within the exercising muscle. Richardson et 
ai. (2 0 0 1 ) were able to assess the distribution of perfusion and metabolic demand {QIVO2 ) 
in exercising human muscle using magnetic resonance imaging techniques to provide 
multiple, localised measurements of both Q and VO2 . chemical shift imaging provided 
images of the phosphorus spectra in different locations of the muscle, yielding an indication 
of PCr breakdown as a sunogate of QO^. Arterial spin labelling magnetically tags arterial 
blood flow, allowing observation of Q to different areas of the muscle. Large variations in 
QIVO2  were found, indicating the existence of areas of under- and over-perfusion relative 
to metabolic rate. Therefore, while studies demonstrating fast Q kinetics suggest that there
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is excess O2 availability for the requirements of the muscle group as a whole, they do not 
prove Q is not the limit in some constituent muscle fibres.
With an in situ canine gastrocnemius muscle preparation, Grassi et al. (1998b) used 
electrical stimulation of the muscle to increase metabolic rate, and a perfusion pump to 
increase Q to exercise steady-state levels prior to the onset of exercise, therefore 
eliminating Q as a limit to QO^. During the condition of elevated Q , QO2  kinetics were 
not speeded, suggesting that Q kinetics were unlikely to have been limiting under control 
conditions.
Using another in situ muscle preparation, Grassi et al. (1998a) attempted to augment 
peripheral or diffusive flux by increasing the O2 partial pressure gradient from capillary to 
mitochondria through imposing a hyperoxic inspirate and infusing a adenosine which 
increases haemoglobin O2 off-loading. Under these conditions, again, the QOj kinetics 
were not speeded, despite the enhanced O2 delivery. MacDonald et al. (1997) studied the 
effects of a hyperoxic inspirate on humans during cycling exercise and similarly showed no 
effect on the VO2  kinetic response.
It has been suggested that nitric oxide (NO) may inhibit enzymes involved in oxidative 
phosphorylation, such as pyruvate dehydrogenase (PDH), cytochrome oxidase and creatine 
kinase (CK). The influence of NO was examined by Kindi g et al. (2002a) after inhibition 
of NO synthase (NOS) with N^-nitro-L-arginine methyl ester (L-NAME) was in horses (i.e.
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synthesis of NO catalysed by NOS). Thus, Kindig et al. (2002a) demonstrated that after L- 
NAME administration VO2  was accelerated (12s vs. 17s). These results therefore 
supported the hypothesis that O2 delivery was not the limiting factor for FO2  kinetics; i.e. 
NO inhibition would, if anything, decrease vasodilation and therefore slow Q kinetics 
(Joyner and Dietz, 1997).
The effect of NOS inhibition in humans has not yet been studied in the moderate-intensity 
exercise domain and therefore it is unknown whether the results of Kindig et al. (2002a) 
apply to humans. Horses have much faster FO2  kinetics than humans suggesting that the 
physiological systems of the two species may not be identical.
The evidence to date therefore demonstrates that O2 delivery, at least during moderate- 
intensity exercise, does not normally limit FO2  kinetics. It is clear, however, that 
techniques to measuring Q directly in the active muscle of human subjects are needed to 
resolve this issue.
1.5.1.2 Feedforward control by pyruvate dehydrogenase activation
Pyruvate dehydrogenase (PDH) is a multi-enzyme complex involved in the conversion of 
pyruvate to acetyl-CoA, a mitochondrial substrate for the Krebs cycle. It has been 
suggested that the lack of sufficient activation of PDH via PDH kinase may limit the
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production of acetyl CoA, thereby limiting the production of the redox substrates NADH, 
and FADH2 and, therefore, ATP production (Howlett et al., 1999; Timmons ah, 1998).
It was shown by Howlett et al. (1999) that, with dichloroacetate (DCA) administration to 
activate PDH (by inhibiting PDH kinase), there was an increase in acetyl CoA and a 
corresponding reduction in PCr degiadation. As PCr breakdown has been shown to be an 
indicator of oxidative phosphorylation increase (McCreary et al., 1996; Whipp et al., 1999; 
Rossiter et ah, 1999, 2002b), Howlett et ah (1999) concluded that there must have been an 
increase in oxidative phosphorylation, although QO2 was not measured in this study.
Campbell-0’Sullivan et ah (2002) increased acetyl group availability by utilising prior 
moderate-intensity exercise and found that VO2  kinetics were correspondingly accelerated. 
However, the VO2  response kinetics were modelled as a mean response time thus including 
the phase I response, which, as described in section 1.4.1, is not a part of the fundamental 
response. Therefore, the results from this study remain inconclusive.
1 ,5 .13  Feedback control by high-energy phosphate status
As ATP is hydrolysed, Pi and ADP are released with free energy (AG). Utilising a model 
for skeletal muscle QO2  control, it was proposed by Chance et ah (1962) that the 
concentration of cytosolic ADP acted as the control for controlling the rate of QO2 . This 
model suggestion initially arose from studies done by Chance and Williams (1956), in
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which they supplied increased levels of ADP to isolated mitochondria. It was shown that 
as [ADP] increased O2 consumption increased; the changes fit Michaelis-Menten kinetics, 
suggesting that a single control step was involved. Using ^^P-NMR, spectroscopy it was 
found that ADP levels were much lower than the Km whereas P, levels were in excess of 
their Km (Michaelis constant) value. Therefore, the [Pi] would not be able to exert the 
many-fold increase required to account for' the large increase in ATP hydrolysis with 
exercise, suggesting that [ADP] was the limiting substrate not [Pi] (Chance et al., 1985). 
The model suggested by Chance et al. (1985) is shown in figure 1.9.
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Figure 1.9. -  Diagram summarising the cytosolic and mitochondrial reactions 
involved in ATP generation. Note the ATP and ADP are shuttled between the 
mitochondria and cytosol via the translocase. From Chance et al., 1985.
As the transport of ATP and ADP into and out of the mitochondrial matrix is via the 
transporter, adenine nucleotide translocase, Klingenberg (1980) suggested that although 
[ADP] was the main controller of the rate of oxidative phosphorylation, the competition 
that ATP employed towards [ADP] for the ADP transporter meant it was the ratio of 
[ATP]/[ADP] that was likely to be the important contiol. In addition, Hochachka and 
Matheson (1992) recognised that in intact, animal, skeletal muscle (rather than isolated 
mitochondria as used by Chance and colleagues, 1956, 1962, 1985), [ADP] at rest was not
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in fact very far below the its Km value. Therefore, they proposed the notion of additional 
involvement of other limiting factors, which would in turn affect the primary substrates 
(ATP and ADP) that were involved in oxidative phosphorylation.
The phosphorylation of ADP to ATP at the level of cytochrome c of the electron transport 
system (ETS) depends on the supply of reducing substrates (NADH and FADH2) that are 
provided by the Krebs cycle. It has been suggested that the ratio of redox substrates (i.e. 
[NAD+]/[NADH], FADH2 being negligible in comparison) may also provide further 
control of QO2  at the onset of exercise. Meyer and Foley (1994) reviewed numerous 
sources that hypothesised a model referred to as “nonequilibrium thermodynamics” in 
which ATP synthesis is a function of the hydrolysis products ([ATP]/[ADP][Pi]), with AG 
driving ATP synthesis as well as the redox potential.
Erecinska et al. (1974), although using a slightly different model referred to as the ‘near 
equilibrium hypothesis’, also suggested that the phosphorylation potential 
([ADP]/[ADP][Pi]) and redox potential ([NAD+]/[NADH]) were interrelated with muscle 
QO2 . This notion was based on evidence that the reduction of cytochrome c oxidase is 
irreversible, and so the overall QO2  would have to be equal to the rate of oxygen reduction 
(therefore the rate-controlling step). Although this reaction is not dependent on redox 
potential, the reaction that supplies the substrate (reduced cytochrome c) is. Further 
discussion of this hypothesis was presented by Wilson (1994). Evidence was based on a 
number of sources in which it was observed that the phosphorylation potential could be
33
manipulated, but respiratory rate was maintained by adaptive changes in redox potential. 
As evidence emerged that the above models might not express the entire process 
controlling oxidative phosphorylation in vivo, investigations into the control of oxygen 
uptake turned to other potential high-energy phosphates involved in oxidative 
phosphorylation.
Bessman and Geiger (1981) proposed that, rather than the control of the rate of oxidative 
phosphorylation being signalled by the phosphorylation potential of ATP/ADP (or 
versions), the phosphorylation potential of [PCr]/[Cr] may provide the control to oxidative 
phosphorylation. Bessman and Carpenter (1985) and Bessman (1986, 1987) compiled 
evidence supporting this suggestion. In particular, it was demonstrated that an isoform of 
creatine kinase exists at the mitochondrial membrane (CK-mi) and that the location of the 
different CK isoforms was associated with the location of the nucleotide translocases for 
ADP/ATP. This “new” model, as shown in Figure 1.10, was termed the ‘creatine shuttle’ 
by Bessman and Geiger (1981). It suggests that the newly produced ATP is channelled 
from the mitochondrial matrix to CK-mi at the inner mitochondrial membrane, which 
phosphorylates Cr into PCr yielding ADP. The PCr then moves into the cytosol to 
rephosphorylate cytosolic ADP to provide ATP at sites of utilisation. In addition, Cr is 
produced and is therefore available to return to the mitochondria to continue the cycle. 
Meanwhile, the ADP that had been produced in the mitochondria is channelled back into 
the mitochondrial matrix for rephosphorylation by oxidative phoshporylation.
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Figure 1.10. Diagram showing the role of phosphorylation potential and creatine kinase 
(CK) in the control of oxidative phosphorylation. From Whipp and Mahler, 1980.
Within this model, CK serves several puiposes: a temporal buffer of ATP/ADP levels; a 
spatial buffer of ATP/ADP; maintaining pH (as H+ is used in rephosphorylating ADP); and 
protecting the cell from ADP accumulation (Wallimann et al., 1992).
This hypothesis gained support from Mahler (1985) who demonstrated that the old model 
by Chance et al. (1985) could only hold in isolated mitochondria. The demonstration that 
[ATP] levels stay constant and there is no cytosolic CK in isolated mitochondria would in
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fact reduce dependence of QO  ^ on [ADP] in a Michaelis-Menten fashion. Mahler (1985) 
therefore measured of QO^, using intact frog sartorius muscle, when a twitch stimulus was 
applied. The muscle was then removed, frozen and examined for [PCr] and [Cr] (and in 
some cases [ATP] and [ADP]). It was observed (as previously reported) that QO  ^
displayed an off-transient response consistent with first-order kinetics (mono-exponential 
for a step function). It was observed that the [PCr] and [Cr] displayed similar first-order 
responses which, when plotted against QO2  ■> also showed linear changes. This confirmed 
PCr' 8 association with the rate of oxidative phosphorylation. Further, the ATP and ADP 
concentrations did, in fact, remain essentially constant in skeletal muscle. Taken together, 
these data when applied to the mathematical equations describing the two models (that of 
Chance compared with Bessman’s creatine shuttle) showed that only the model of the 
creatine shuttle could hold.
Meyer et al. (1988) confirmed this conclusion using ^*P-NMR spectroscopy in intact 
skeletal muscle (rat gastrocnemius) to observe [PCr], thereby eliminating any experimental 
error involved in removal of the muscle and freezing as utilised by Mahler (1985). The 
results confirmed those of Mahler (1985), in that there was a mono-exponential off- 
transient increase for [PCr], and further showed that the [PCr] on-transient was also mono­
exponential and that rate of PCr changes were independent of work rate. Both the 
independence of the rate of PCr change with the work rate and the symmetry of the on- and 
off-kinetics provided additional evidence that PCr displayed first order kinetics.
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The natural extension of the PCr work by Mahler (1985) (as mentioned above) was to 
attempt these observations in humans. Yoshida and Watari (1993) using ^*P-NMR 
spectroscopy demonstrated that at the onset of femoral flexion exercise in humans, [PCr] 
decreased in an exponential fashion with a time course that was not dependent on exercise 
intensity and showed on-off symmetry. McCreary et al. (1996) used ^^P-NMR 
spectroscopy during calf exercise in human subjects to demonstrate that the kinetics of PCr 
degradation and increase were similar. However, VO2  and PCr were not measured 
simultaneously and, although many repeats were performed ( 1 2 ) the small muscle mass 
limited the ability to resolve kinetics with high confidence (Rossiter et al., 1999). Recently, 
the ability to simultaneously measure PCr breakdown and VO2  in a larger muscle mass 
(quadriceps exercise) in humans has shown that indeed the time constants of PCr and VO2  
are the same during moderate-intensity exercise (Whipp et al., 1999; Rossiter et al., 1999, 
2002).
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Figure 1.11 Similarity of the kinetics for VO2  and PCr degiadation at the onset of moderate 
intensity exercise. From Rossiter et al., 2002.
1.5.2 Above the laetate threshold
1,5.2.1 O 2 delivery
1.5.2. LI Evidence for O2  deliveiy as a limitation
A number of studies have shown that when muscle O2 delivery is impaired, VO2  kinetics 
during heavy-intensity exercise were slowed. Hughson et al. (1996) altered forearm blood 
flow during ‘high power output' arm exercise by utilising exercise above and below the
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heart. It was found that forearm blood flow and VO2  kinetics were both slower when the 
aim was above the heart compared to below. Similarly it has been shown that VO2  kinetics 
are slowed when O2 delivery is limited by breathing a hypoxic gas mixture (Hughson and 
Kowalchuk, 1995) or by breathing carbon monoxide (Koike et al., 1990).
In contrast, other studies have utilised different interventions in attempts to demonstrate 
that, with an increased muscle blood flow, VO2  kinetics are speeded. During supine 
cycling, with a decreased Q to the exercising limbs, Hughson et al. (1993) added lower 
body negative pressure to compensate for the decreased Q, and noted that VO2  kinetics 
were accelerated to resemble those of upright exercise. It has also been shown that when 
breathing a hyperoxic gas mixture, faster VO2  kinetics ensue (Hughson and Kowalchuk, 
1995; MacDonald et al., 1997). Utilising the same in situ muscle preparation method 
mentioned previously (Grassi et al., 1998b), but eliciting an exercise intensity of 100% 
VO2  max, Grassi et al. (2000) showed that when Q was elevated to the exercise steady state 
level prior to the transition QO2  was slightly faster.
Another method that has been used to increase Q is to perform a prior bout of heavy 
cycling exercise, which was suggested to result in an acidic-induced vasodilation and/or 
enhanced O2 unloading from haemoglobin (Gerbino et al., 1996). In these studies there 
was a speeding of VO2  kinetics on the subsequent bout of heavy-intensity cycling exercise, 
suggesting O2 delivery may play a role in the rate of oxidative phophorylation (Gerbino et
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al., 1996; MacDonald et al., 1997; Bohnert et al., 1998;). However, it has also been 
suggested that prior exercise could modulate enzyme activity status, such as that of PDH 
(Gibala and Saltin, 1999). In addition, the effects of prior exercise on VO2  kinetics have 
been re-evaluated recently. The previously-mentioned studies characterised VO2  response 
in terms of a mean response time rather than discerning the fundamental phase from the 
other components of the response. Subsequently, Burnley et al. (2001) have demonstrated 
that during cycling exercise, with the different phases being modelled separately, the 
fundamental phase (phase II) was not faster. Rather, the amplitude of the slow component 
of the response was smaller, and this factor decreased the mean response time. 
Interestingly, with alternate leg knee extension exercise, it was found that the Phase II 
response was faster on the 2 "^  bout, and that the slow component was also reduced 
(Rossiter et al., 2001).
Therefore, in contrast to the previous suggestion that O2 delivery may be limiting Vo2  
kinetics, as faster VO2  kinetics resulted after prior exercise (Gerbino et al, 1996; Bohnert et 
al., 1998; MacDonald et al., 1997) more recent results present conflicting evidence as to the 
impact of prior exercise on VO2  kinetics (Burnley et al, 2001; Rossiter et al., 2001). The 
results to date suggest that a muscle-specific response exists or that the response is 
dependent on the total muscle mass involved, as whole-body prior exercise did not elicit a 
speeding of VO2  kinetics, when modelled appropriately (Burnley et al., 2001), whereas 
alternate leg rhythmic knee extension did (Rossiter et al., 2001).
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1.5.2.1.2 Evidence against O2  delivery as a limitation
Similar to the study of moderate-intensity exercise as mentioned earlier (section 1.5.1.1,2), 
Grassi et al. (2000) utilised hyperoxic inspirate to increase the rate of peripheral O2 
diffusion by increasing the O2 partial pressure gradient from capillary to mitochondria. 
This was done through inspiration of a hyperoxic gas mixture and by L-NAME 
administration. No effect on the VO2  kinetics at 100% max was found.
Utilising one-legged training, it was demonstrated that VO2  kinetics were accelerated in the 
trained leg (Bell et al., 2001b), despite an unchanged mean blood velocity measured at the 
femoral artery using Doppler ultrasound. However, citrate synthase activity was increased 
in the trained leg, suggesting that the acceleration of the VO2  kinetics was not due to 
increased O2 delivery, but rather to an improved rate of O2 utilisation.
Recently, Bangsbo et al. (2000) used thermodilution and indocyanine green techniques to 
measure Q while QO  ^ was simultaneously measured across the femoral artery and vein.. 
The indocyanine green allowed calculation of the time delay from the site of blood-tissue 
exchange to the measurement site. It was demonstrated that leg Q increased immediately 
and in excess, whereas QO  ^ did not increase until 6 s later, indicating that Q was unlikely 
to be the limiting factor for the for QO  ^ response.
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As discussed in moderate intensity exercise (section 1.5.1.1.2), the effect of L-NAME on 
NOS and therefore NO was examined in the horse. Similar to the findings for moderate 
intensity exercise, VO2  kinetics in the horse were speeded with L-NAME infusion (Kindig 
et al., 2001). The role of NO in humans is questionable, however, as Frandsenn et al.
(2001) did not find any effect of L-NAME in humans performing both submaximal and 
exhaustive knee extension exercise. Although, it is important to note that the kinetics of the 
VO2  response were not estimated, but rather VO2  was monitored at only 1 0  minute 
intervals.
1.5.2.2 Feedforward control by pyruvate dehydrogenase
Studies investigating the effect of PDH on VO2  kinetics, have utilised PCr breakdown 
measurements as a proxy of oxidative phosphorylation. Timmons et al. (1998) showed that 
after dichloroacetate (DCA) infusion to activate PDH kinase there was a decrease in PCr 
degradation of approximately 50% during submaximal exercise. This suggests a smaller O2 
deficit and therefore faster VO2  kinetics.
In contrast, Savasi et al. (2002) showed that with cycling exercise at 90% VO2  max DCA 
infusion had no effect on PCr breakdown or [La] (as an indicator of pyruvate build up). 
Grassi et al. (2002), using the in situ canine muscle preparation, also demonstrated that 
DCA had no effect on PCr breakdown, lactate production or QO2 kinetics. Bangsbo et al.
(2 0 0 2 ) showed a similar result in humans during severe intensity knee extension exercise;
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Vo2  kinetics were not speeded despite elevated PDH levels within the first 15s of exercise, 
and neither were PCr degradation and blood lactate values reduced.
The most recent of these results therefore strongly suggest that PDH does not limit Vo2  
kinetics during heavy-intensity exercise.
1.5.2.3 Feedback control by high energy phosphate status
With the knowledge that VO2  kinetics in heavy intensity exercise do not display the same 
mono-exponential kinetics as shown for moderate exercise, reflecting existence of a slow 
component (see section 1.4.2), a recent study utilised ^*P-NMR spectroscopy during heavy- 
intensity exercise to simultaneously observe kinetics of VO2  increase and PCr breakdown 
(Rossiter et al., 1999). It was found that PCr and VO2  did not show similar phase II t  
values. In addition, as briefly discussed above (section 1.5.2.1.1) this study also 
investigated the effects of a prior bout of heavy intensity exercise. It was found that when 
the VO2  kinetics were speeded on the second bout, there was a lesser decrease in [PCr] (for 
the second bout); however, the rate of PCr breakdown was not speeded. The observation 
that there was a modulation of PCr dynamics when VO2  was also modulated supports the 
involvement of the creatine shuttle model. However, the non-linearity between the amount 
of PCr breakdown for the same work rate increment, and the multi-compartment and
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complex dynamics of the PCr response suggests that the relationship between the VO2  and 
PCr kinetics is more complex and may be modulated by other factors than just the rate of 
the creatine shuttle. However, the most recent work by Rossiter et al. (2002) has shown 
conflicting results, as PCr and Vo^  kinetics were found to be similar in heavy-intensity 
exercise as shown in Figure 1.12. The reason for this discrepancy is unclear.
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Figure 1.12. Similarity of the kinetics for VO2  and PCr degradation at the onset of heavy- 
intensity exercise. The solid line represents the model fit for phase II and the dashed line 
indicates the extension of that fit, therefore demonstrating the appearance of a slow 
component. From Rossiter et al., 2002b.
1.5.3 Muscle metabolic heterogeneity
It has been shown that there is significant heterogeneity of blood flow within the exercising 
muscle in animal models (e.g. Piiper, 1989, 1991, 1992, 1999, 2000). As discussed in 
section 1.5.1.1.2, Richardson et al. (2001) has recently confirmed this heterogeneity of 
blood flow and in addition demonstrated that heterogeneity of QO2  exists with in the 
muscle in humans.
To address the issue of heterogeneity, the recent advance of phosphorescence quenching 
techniques has allowed measurement of the intracellular partial pressure of O2 (PiOz) in an 
isolated single frog skeletal muscle fibre (Hogan et al., 1999, 2001), and micro vascular 
partial pressure of O2 (PmOz) in rat skeletal muscle (Behnke et al., 2001, 2002a, 2002b) in 
response to electrical stimulation. The intensities elicited by the electrical stimulation 
cannot be categorised, and therefore the results of these experiments are discussed without 
reference to a particular exercise intensity domain. Electrical stimulation elicits concurrent 
fibre activation and has the benefits over volitional muscle activation of eliminating 
variable factors such as motor unit activation patterns and muscle fibre recruitment. The 
quenching method measures the length of the phosphorescence lifetime of a porphyrin 
probe, when exposed to a flash of light. As the lifetime is dependent on PO2 , an index of 
the PO2 in the environment is obtained.
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The recent studies of Hogan (Hogan, 1999; Howlett and Hogan, 2001) have demonstrated a 
decrease in PjOi when electrically stimulated contractions were initiated. The fall in PjOi 
mirrored the intramuscular oxygen uptake kinetics and, in addition, a linear relationship 
existed between the decrease in PjOz and stimulation frequency (measure of energy 
demand) (Howlett and Hogan, 2001), supporting its use as an index of QO^. At the onset 
of contractions, there was evidence of a delay period of ~13s preceding a subsequent mono­
exponential decrease in PjOi to steady state (Hogan et al., 1999).
The measurement of PmOi therefore provides an indication of the overall QO^IQ ratio. 
That initial delay in the fall of PmOg suggested therefore that QO  ^ was proportionally 
matched by Q; and, in fact, in some cases an initial increase in PmOi was observed, 
suggesting a hyper-perfusion and therefore requiring a reduced O2 extraction (Behnke at ah, 
2001). Further, Behnke at al. (2002b) demonstrated that a prior bout of contractions 
decreased the time delay from 12.2s to 5.7s therefore speeding the QO  ^ response. This was 
despite no elevation in Pm0 2  baseline, which would have indicated increased Q .
These results therefore suggested that O2 delivery does not limit QO  ^ at least in this model. 
Rather, the intracellular utilisation of O2 in the process of oxidative phosphorylation would 
appear to be limiting. Recent work by Behnke et al. (2002a) combined Pm0 2  and capillary 
red blood cell flux (Kindig et al., 2002) to resolve the time course of microvascular QO^. 
The results led to the conclusion that the apparent delay in Pm0 2  is related to sufficient
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delivery compensating for the need for increased extraction, rather than an actual delay in 
oxidative phosphorylation occurring.
In addition, the method for measuring PiOz was recently used by Howlett and Hogan (2002) 
to investigate the effect on PiOz of increasing the activation of PDH via DCA 
administration (see section 1.5.1.1.2). It was found that, with DCA, the time delay was 
similar but the P1O2 dropped more rapidly, indicating a faster activation of oxidative 
metabolism.
The above evidence measuring Pi0 2  and Pm0 2  therefore lends support to the hypothesis of 
metabolic inertia as a limiting factor to VO2  kinetics, with PDH possibly playing a role. 
However, it is important to note that these results may not provide a direct indication of 
human muscle mechanisms in vivo.
1.6 CONTROL OF THE VO 2 SLOW COMPONENT
The mechanisms responsible for the slow additional rise in VO2 , seen in heavy-intensity 
exercise, remains to be elucidated (reviewed in Whipp, 1994; Poole et al., 1994). Several 
theories have been suggested over the past years, some of which have subsequently been 
disproved with some certainty; these are therefore discussed first.
47
1.6.1 Muscle temperature and increased respiratory, cardiac and upper body work
Two hypotheses that generally have been dispelled as possible causes of the VO2  slow 
component were that it was related to an increase in muscle temperature that occurs with 
heavy-intensity exercise (Hagberg et al., 1978; Poole et al., 1988), and the possibility of an 
increase in the O2 cost due to the greater respiratory, cardiac and/or upper body work 
(Hagberg et al., 1978; Wasserman et al., 1995). Koga et al. (1997) and Poole et al. (1988) 
addressed the possibility of muscle temperature and demonstrated that exercising with an 
increased muscle temperature did not result in an increase in the slow component.
Recently, evidence from Ozyener et al. (2001) has demonstrated that a VO2  slow 
component is not discernable in the off-transient VO2  response of heavy-intensity exercise. 
If the above hypotheses were causes of the slow component, it would be expected that at 
the offset of exercise the cessation of these influencing mechanisms would be manifest in 
the Vo2 response. In addition, it has been reported that the slow component resides within 
the muscle. Poole et al. (1991) reported a high correlation between the slow components of 
VO2  and of QO2  measured across the exercising muscle and suggested that QO  ^ could 
account for at least 8 6 % of the VO2  slow component. In addition, Rossiter et al. (2002a, 
2 0 0 2 b) have reported with ^^P-NMR spectroscopy that there is a slow component evident in
the [PCr] decline at exercise onset, indicating it is likely there is an energetic manifestation ; |■f;
of the slow component within the muscle.
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1.6.2 Lactate concentration
Another intriguing hypothesis was that [La] may be responsible for the slow component as 
it was shown that there was an association between the arterial [La] and the VO2  slow 
component (Roston et al., 1987; Poole et al., 1988) and between the onset of the [La] 
increase and the slow component (Poole et al., 1988). In addition, after training, the 
decrease in the slow component was also associated with a decrease in [La] (Poole et al., 
1990). However, the most recent evidence more likely reported that the [La] is not the 
cause of the slow component, but rather a coincidental association. For example, Gaesser 
et al. (1994) demonstrated that with training the decrease in the VO2  slow component was 
not compatible with the time course of the decrease in [La]. In addition, after prior infusion 
of adrenaline, an increase in [La] was seen but there was no change in the VO2  slow 
component (Gaesser et al., 1994). In a study in which the blood [La] was decreased by 
administration of acetazolamide (presumably slowing its removal from the muscle and 
thereby increasing muscle [La]), it was found that there was no corresponding alteration in 
the slow component magnitude (Sheuermann et al., 1998).
A more direct approach was taken by Poole et al. (1994). After infusion of [La] into the 
arterial blood supply of an isolated canine muscle preparation, there was an increase in 
intramuscular [La] but no additional increase in the QO2  slow component.
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1.6.3 Fibre type recruitment
The hypothesis that has received the most focus recently has been with regard to the 
possibility that the slow component is due to an increase in the recruitment of type II fibres. 
It has been demonstrated, although with in vitro animal preparations, that type II fibres are 
less efficient in terms of the ATP production per O2 used (Crow and Kushmerick, 1982; 
Kushmerick et al., 1992). This is possibly due to type II fibres use of the a- 
glycerophosphate shuttle instead of the malate-aspartate for transport of NADH into the 
mitochondria (Crow and Kushmerick, 1982; Kushmerick et al., 1992). Therefore, if a 
greater proportion of type II fibres are recruited in heavy exercise, the aerobic inefficiency 
of these fibres may result in the additional VO2  apparent with the slow component. It was 
of interest therefore that Barstow et al. (1996) demonstrated a significant conelation 
between an individual’s percentage of type II fibres and the VO2  slow component 
amplitude.
The most recent studies have therefore utilised electromyography (EMG) to determine 
whether the onset of the slow component might in fact be associated with an additional 
recruitment of type II fibres. It was shown by Shinohara and Moritani (1992) that at the 
onset of the slow component there was in fact an increase in the integrated EMG signal, 
indicating there had been an increase in overall motor unit recruitment. However, 
Scheuermann et al. (2001) suggested that the EMG signal expressed as a mean power 
frequency (MPF) spectrum was required to identify whether there was a change in the
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proportion of type I and type II motor units recruited. It was found by Scheuermann et al.
(2001) and Lucia et al. (2000) that, in contrast to the results of Shinohara & Moritani 
(1992), there was no increase in the integrated EMG or a change in the MPF throughout 
exercise, despite evidence of a VO2  slow component. Burnley et al. (2002) used integrated 
EMG and MPF but studied more of the exercising muscle groups (as only two were studied 
in that of Scheuermann et al. (2001)). It was demonstrated that there was an increase in 
both signals at the onset of the VO2  slow component. Most recently, however, the use of 
MPF and integrated EMG to identify the recruitment of type II fibres has been questioned 
(Borrani et al., 2001).
Rossiter et al. (2002a) has used ^^P-NMR spectroscopy to discern intramuscular areas of 
high and low pH indicated by a splitting of the inorganic phosphate peak (Pi), which have 
been proposed to reflect the recruitment type I versus type II fibres (Yoshida and Watari, 
1993). However, this split was only observed in some subjects and the split occurred 
between 35 and 235 s after exercise onset. This indicated that the Pi splitting did not reflect 
the FO2  slow component response, as the slow component has been shown to consistently 
occur at ~ 1 2 0 s as described previously and this was obseiwed in all of their subjects.
Therefore, whether the recruitment of type II fibres is responsible for the slow component 
remains to be elucidated.
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1.6.4 Uncoupling proteins
The role of the mitochondrial uncoupling proteins (UCP) in the manifestation of the slow 
component was recently studied by Russell et al, (2002). It was suggested there may be a 
positive correlation between the expression of UCP-3 mRNA (but not UCP-2) and the 
amplitude of the slow component. Although the specific function of UCP-3 is still 
unknown, it has been suggested by Brand et al. (1994) that it may be involved in the leak of 
protons across the inner mitochondrial membrane at rest when ATPase at the inner 
mitochondrial membrane is not stimulated at a high rate. Although this allows for the large 
increases in ATP production required when performing exercise, it may be that the 
existence of high concentrations of UCP-3 may still allow a leak of protons even at high 
metabolic rates, therefore decreasing the ATP production for O2 consumed i.e. reducing 
efficiency. In addition, it may be that the UCP-3 proton leaks may be more abundant in 
type II fibres as it was shown by Russell et al. (2002) that there was a positive correlation 
between UCP-3 and of the proportion type Ila muscle fibres.
1.7 CONCLUSIONS AND OBJECTIVES FOR THE PRESENT STUDY
It is apparent that despite the numerous studies in the area, the evidence to date regarding 
the control of VO2  kinetics during exercise in humans remains inconclusive. It appears that 
if  O2 delivery is a limiting factor, it may play more of a role in heavy-intensity exercise 
rather than in moderate-intensity exercise. The studies regarding metabolic inertia through
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muscle PDH activation suggest it is probably not a limit at either intensity, at least in vivo 
in humans. Studies showing close matching of the kinetics of PCr breakdown with those of 
VO2  provide compelling evidence that the limit to VO2  kinetics may reside within the 
muscle and involve high-energy phosphate status, although the specific mechanism is not 
apparent from these studies.
The enzyme involved in the breakdown and rephosphorylation of PCr is CK. Many studies 
have attempted to investigate the role of the CK reaction in mitochondrial respiration. 
However, most of the studies have examined the steady-state response (Chance et al, 1985; 
Meyer 1988; Saks et al, 1995; Walsh et al., 2001a, 2001; Zoll et al., 2002). In addition, 
these measurements were made using isolated mitochondria (Chance et al., 1985; Saks et 
al., 1995) or isolated muscle (Saks et al., 1995; Tonkonogi et al., 1998; Walsh et al., 2001a, 
2 0 0 1 b), and thus direct conclusions regarding human skeletal muscle in the in vivo state 
cannot be made. However, it is clear that the CK-catalysed reaction plays an important role 
in mitochondrial respiration. Therefore, this study investigated whether the CK activity 
rate was associated with the rate of aerobic ATP production at the onset of exercise.
It has been established that different isoforms of CK exist with in skeletal muscle 
(Wallimann et al., 1992). The cytosolic iso forms muscle (M) and brain (B) form dimeric 
isoenzymes MM, MB and BB. However, CK-B is only expressed during muscle cell 
differentiation until the myoblast undergoes a transitional development to the myotube 
(Trask and Billadello, 1990). The sarcomeric mitochondrial CK isoform in humans is an
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octomeric isoenzyme located at the outer surface of the inner mitochondrial membrane. 
Therefore, this study also attempted elucidated the CK isoform distribution and establish 
whether a correlation exists between an individual’s isoform distribution and the VO2  
kinetics during exercise.
The mechanism of the VO2  slow component still remains to be elucidated. Although the 
recent study by Russell et al. (2002) suggested UCP-3 may have a role, several design 
shortcomings related to the selection of appropriate exercise intensities and the 
characterisation of the VO2  kinetics render the conclusions questionable. In Russell et al.
(2 0 0 2 ) the most reliable techniques for identification of the Ol were not used, and thus the 
relative exercise intensities used in each individual to elicit the VO2  slow component may 
vary considerably. Breath-by-breath gas exchange with a ramp increase in WR provides 
many serial measurements allowing precise identification of the Ol (Beaver et al., 1986; 
Whipp et al., 1986). However, Russell et al. (2002) sampled [La] every four minutes 
during an incremental WR test of square-wave WR increases every four minutes, initiated 
from a work rate of 40% of the individual’s peak power output. Therefore, there would be 
relatively few data points below Ol and the minimal sampling rate would result in a 
curvilinear response, making precise identification of the Ol difficult. Further, 
measurement of [La] at the antecubital vein does not provide an appropriate reflection of 
[La] from the exercising legs as the muscle of the arm would consume the [La] (Brooks et 
al., 2000), especially as artérialisation of the blood was not performed. As a result of 
imprecise Ol identification, the work rates performed may not have been of the same
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relative intensity between subjects. As the VO2  slow component amplitude varies with 
relative intensity (Whipp and Ward, 1992: Whipp et al., 2002) it is imperative similar 
intensities be performed by the subjects if the goal is to relate the slow component 
amplitude to other factors. Further, in the study of Russell et al. (2002) the amplitude of 
the slow component amplitude to other factors. Therefore, a further purpose of the present 
investigation was to examine the relationship between the amplitude o f the slow component 
during very heavy intensity exercise and the expression of uncoupling proteins.
A  final puipose related to the identification of the parameters of the VO2  response during 
very heavy intensity exercise. Although Ozyener et al. (2001) studied the VO2  response 
within this exercise intensity domain, a double exponential model was used to fit the data, 
which has little a priori physiological justification (see section 1.4.2 for details). Therefore, 
the VO2  parameters within the very heavy intensity domain have not been sufficiently 
elucidated using the appropriate method of slow component identification described 
previously (Rossiter et al., 2001). The present investigation thus also examined the 
existence of inter-subject VO2  parameter variability, in response to very heavy-intensity 
exercise, using appropriate modelling, to compare kinetic parameters for two different 
work rates, within the very heavy intensity domain.
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CHAPTER 2
METHODS
2.1 SUBJECTS
Six male subjects volunteered to take part in the study. The study protocol was approved 
by the University of Glasgow Ethics Committee (appendix i) and subjects provided written 
informed consent. All subjects were non-smokers and recreationally active. The subjects 
participating in this study had a mean age of 22+2 years, height of 179+5 cm and mass of 
77+7 kg (Table 2.1). There was a variable range of aerobic fitness indicators demonstrated 
by a range of Fo^peak values from 45 to 56 ml.kg"\min"\ values ranging from 1.40 to 
2.55 l.m in'\ and expressed as a percent of peak ranging from 37 to 53%. Individual 
values are shown in Table 2.1.
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A medical questionnaire (appendix ii) was used to ensure there were no pre-existing health 
conditions which would affect the response to exercise, such as asthma or a family history 
of sudden death, which may increase the risk associated with performing strenuous exercise 
tests. In addition, a physician medically screened all subjects, including a resting 12 lead 
electrocardiogram and blood pressure measurement. To maximise controlled conditions as 
much as possible, subjects were instructed not to: perform strenuous exercise for 48 hours, 
consume alcohol for 24 hours, ingest caffeine for 4 hours, or consume food for 2 hours 
prior to exercise testing. If any subject was not able to adhere to the criteria on a particular 
visit or was feeling ill, injured or fatigued, the test was postponed until the subject 
recovered.
All subjects were familiarized to the laboratory, equipment and all experimenters involved. 
The cycle seat and handlebars were adjusted to maximise comfort and these settings were 
recorded and used for each test. Prior to each protocol the details of the test were explained 
to the subject. During the testing music was played, monitoring equipment was kept out of 
the subject’s view, audible alarms were turned off and talking among experimenters was 
avoided. At the end of testing subjects were allowed to rest, re-hydrate and shower, after 
which they were thanked for their time and escorted from the laboratory.
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2.2 MEASUREMENTS
2.2.1 Work rate
All exercise testing was performed on a computer controlled cycle ergometer (Excalibur 
Sport, Lode BV, Gronigen, Netherlands). The power output is linear over the range of 10- 
1000 W, independent of cadence between 30 and 120 ipm, and is accurate to < 2% from 20 
W (Lode, Excalibur Sport Operator Manual V2.0, 1994). Instantaneous changes in work 
rate occur at a rate of up to 1000 W/s and a constant work rate is ensured, independent of 
pedalling rate, by altering the instantaneous resistance in proportion to changes in cadence. 
An electrical signal proportional to the work rate was relayed to the computer for data 
output. In addition, work rate was recorded on a digital chart recorder run at Imm/s for 
reference purposes when editing the data as described later. The ergometer was calibrated 
using a motor-driven torque calibrator (VacuMed, model 17800, Ventura, California, 
USA).
2.2.2 Gas exchange
Subjects breathed through a mouthpiece unit from which gas was drawn continuously by a 
capillary tube sample line. Respired [O2], [CO2] and [N2] were measured every 2 0 ms by 
quadrupole mass spectrometer (QP9000, Morgan Medical, Kent, UK), which was 
calibrated against two precision-analysed gas mixtures of concentrations which spanned the
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range seen during exercise. A bi-directional, low resistance, low dead space (90ml) turbine 
and volume transducer (Interface Associates Inc., Laguna Niguel, California, USA) 
attached to the mouthpiece unit was used to measure inspired and expired flows and 
volume continuously. Prior to each test the turbine was calibrated using a 3.0 L syringe 
(Hans Rudolph, Kansas City, USA) and the measured value was accepted if it was within
0.2% of 3,0 L. The flow signal was relayed to the computer instantaneously. However, as 
there is a physical transit delay for the gas sample transport down the capillary line, the 
flow and gas concentration signal required time alignment. To measure the amount of time 
alignment necessary, the time delay for a high velocity, high concentration bolus of CO2 
gas to pass from the sample line to the analysis system was determined and recorded on 
chart paper at 100 mm/s. The delay was then calculated as the time from the voltage signal 
of the solenoid switch (time zero) to the time to reach 63% of the steady state increase of 
the CO2 rise.
Immediately before the test the gas concentrations were checked to ensure they were within 
1% of the values that had been accepted for calibration. At the end of the test the gas 
concentrations were re-checked to ensure they were within 1% of the gas concentration 
measured prior to the test. Respired gas concentration and volume profiles were also 
recorded on the digital chart recorder (Astro Med, Rhode Island, USA) to be used later for 
data editing purposes.
The signals collected throughout the tests from the mass spectrometer and turbine 
transducer were converted from analog to digital format. Breath-by-breath calculations for
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VO2 , VCO2 , ventilation ( V e  ), partial pressure of O2 (Pet0 2 ) and partial pressure of CO2 
(PETCO2) and were performed based on the algorithms of Beaver et al. (1973). These 
algorithms calculate pulmonary gas exchange over the duration of a single breath, whereby 
the continuously-measured expired flow and gas concentration signals are divided into 
consecutive temporal samples (At) of 2 0 ms, which is the mass spectrometer sampling 
interval. Therefore, V e  is measured by the equation:
T
Vs = T  Vexp(t + At) • At [2.1 ]
t= 0
where Vexp is the mean flow rate during the time interval t + At, minute ventilation ( V e ).
VO2  is calculated by the product of the gas concentration and the expired flow for each 
small sampling period by equation:
T
VO2  = Z Vexp(t + A t). At • [(AF0 2 )ti'ue] [2.2]
t= 0
where AFO2 for true is given by:
[(AF0 2 )true] — (F1O2 — FgO? — FiO? » FeC0?1 [2.3]
("I-F1 6 2 )
61
where F1O2 is the fraction of inspired O2 and Fe0 2  is the fraction of expired O2 . Minute 
ventilation (Fe) or VO2  is obtained by summing Fe' or FO2  across the duration of an 
expiration and dividing by the time for expiration. The calculation of FCO2  is based on the 
same principle as FO2 .
2.2.3 Heart rate and arterial saturation
Heart rate (HR) was measured beat-by-beat throughout the test using a six lead ECG 
configuration (Quinton Medical 710, Kent, UK). Paper recordings were made at various 
times during the test to ensure no cardiac abnormalities occurred. Arterial O2 saturation 
was measured continuously and non-invasively at the ring finger using pulse oximetery 
(Satellite Trans, Datex Engstrom, Helsinki, Finland) to ensure saturation did not fall below 
85%; were this to occur (which it did not), the test would be stopped immediately.
2.2.4 Blood lactate samples
Blood lactate was measured fi'om a ~30 pi fingertip blood sample using an automated 
lancet (Autoclix, Boehringer, Germany), collected in 50 pi capillary tubes prepared with 
heparin, fluoride and nitrite. Prior to the test, the subject’s hand was bathed in hot water 
(42-44°C) to obtain vasodilation and thus to arterialise the capillary blood. The first sample 
of blood after the puncture could contain damaged cells and therefore was discarded. The
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subsequent sample was capped and stored on ice until analysis, which was performed 
within 1 hour after sampling, using an automated lactate analyzer (Analox GM-7, Analox 
Instruments, London, UK). A calibration and re-calibration were performed using an 8 mM 
standard. Blood samples were accepted when two measurements of the same sample were 
within 0.2 mM of each other
2.2.5 Muscle biopsies
Each subject had a resting muscle biopsy taken from the lateral head of the quadriceps 
femoris using the Bergstrom needle biopsy technique (Bergstrom, 1962) with suction. This 
biopsy was taken by an experienced physician. A local anesthetic (lidocaine) was used to 
decrease the discomfort of the subject. A small incision (4-8 mm) was made into the skin, 
which allowed for entry of the fine needle, which took 50-150 mg of muscle. The incision 
was then covered with gauze for three days to avoid infection at the incision. Samples were 
immediately frozen in liquid nitrogen and subsequently stored at -84 °C.
2.3 PROTOCOLS
2.3.1 Familarisation
The first visit was a familiarisation protocol consisting of 4 minute step transitions in work 
rate from 20 W to 70 W to 20 W which was then repeated if the subject’s breathing was
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erratic, or it appeared that he had not adjusted to the novelty of the breathing apparatus. 
Subjects were instructed to pedal at a comfortable cadence of 45-55 rpm throughout the 
test. Subsequently, an incremental ramp test of 3W/12sec (15W/min) was performed to the 
limit of tolerance, determined by when subjects could no longer continue to pedal at a 
cadence of 60 rpm or greater. These familiarisation tests were designed to minimise the 
physiological response to stress and discomfort that could contaminate the response 
measured on subsequent trials.
2.3.2 Protocol for moderate-intensity exercise
A second incremental maximal exertion test as described above was performed for the non- 
invasive estimate of the lactate threshold (^l)- On two subsequent visits subjects performed 
a total of 5-6 step transitions in work rate. Subjects were initially at rest on the cycle and 
were not insti’ucted to begin pedalling until it was established that they were comfortable 
and no longer hyperventilating, indicated by a RER around 0.8, a PetC0 2  of 6 % and a V e 
of less than 10.0 L/min. Subjects then began cycling at a comfortable cadence between 45- 
55 rpm at 20 W to achieve unloaded pedalling (so the only energy expended was in rotating 
the legs). This was continued for a minimum of 3 minutes, until Vo^  and RER were stable 
at which point the work rate increased instantaneously ( 1 0 0 0 W/s) to a work rate 
corresponding to 90% 6i, which was continued for 6  minutes. The work rate was then 
instantaneously returned to 20 W for a minimum of 6  minutes of recovery, until Vo2  and 
RER were stable. A second transition similar to the first was then repeated. Subjects then
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rested off of the cycle for a minimum of 15 minutes and, if they were then comfortable 
enough to do one more repeat, the same protocol was repeated but with only one transition 
(20 W to 90% 9l to 20 W).
2.3.3 Protocol for power-duration tests
On differing days (with a minimum of 48 hours between tests), subjects performed 3-5 step 
tests of supra CP exercise (work rates estimated based on the maximum work rate from the 
incremental test) to the limit of tolerance, for determination of the power-duration curve 
(see section 2.4 for details). The order of the periods of exercise was randomised and 
subjects were not informed of the work rate that was to be performed. Subjects began on 
the cycle at rest and were not instructed to begin pedalling until breathing was normal as 
described above. Subjects then began pedalling at 20 W for a minimum of 3 minutes. 
Within one second before the instantaneous transition to the higher work rate, (i.e. 
insufficient time to allow for any “startle” response) the subjects were instructed to increase 
their pedalling rate to overcome the inertia associated with the large increase in resistance. 
Subjects then cycled at the given work rates, at a cadence comfortable for them (ranging 
from 65-85 rpm) to the limit of tolerance, determined when the cadence dropped more than 
15 rpm below the pedal rate they had selected throughout the test despite verbal 
encouragement.
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2.3.4 Protocol for very heavy exercise tests to 6 and 12 minutes of fatigue
Based on the power duration curve profile, work rates that would correspond to 6  minutes 
( “ 6  minute”) and 12 minutes (“12 minute”) of fatiguing exercise were estimated. Subjects 
then performed 2-4 repeats at each of these work rates (protocol as above for the power 
duration tests), until 2 repeats with similar times (within 30s of each other) and similar peak 
Vo2  and HR values were obtained. Trials that did not meet these criteria were discarded. 
In addition, finger prick blood samples were taken for [La] on each of the tests. Samples 
were taken at rest, after 3 min of 20 W exercise and 10 sec before estimated exhaustion or 
at exhaustion if it ensued earlier than estimated.
2.4 ANALYSIS
2.4,1 Determination of the lactate threshold
Prior to analysis, the breath-by-breath gas exchange data were initially edited for ‘bad’ data 
points based on visual inspection of ‘mis-triggers’ of a true breath, due to coughing, 
swallowing, sighs or movement on the cycle. These responses result in mis-calculated 
values or values that were out of the range of the true VO2  response.
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The lactate threshold (^l) was determined non-invasively from pulmonary gas exchange 
data. At the 6l an additional, non-metabolic production of CO2 occurs due to the buffering 
of lactic acid by the bicarbonate reaction:
La'+H*+Na  ^(or K.+)HC0 3 " -wHzCO, WCO2 +H2 O [2.4]
The increase in CO2 production is also associated with an increase in V e . This increase in 
V e is thereby out of proportion to VO2 . Therefore the following gas exchange variables 
were plotted against VO2  : VCO2  (V-slope), respiratory exchange ratio (RER), the 
ventilatory equivalents (Fc/FO^ and VE/VCO2 ) and end-tidal gas tensions (PetC0 2  and 
PETO2). Averaging of the data over a variable number of breaths was performed to obtain 
the most appropriate visual image for determining the location of the 9u based on the 
following criteria (Beaver et al., 1985; Whipp et al., 1986):
(a) a more positive (increased) slope in VCO2  vs. Fo^ ;
(b) an increase in V e  / VO2  with no change in V e  / VCO 2 ;
(c) the onset of an increase in PetÛ2 with PetC0 2  reaching the apex of its increase or 
remaining constant.
The 0L identification for a representative subject is shown in Figure 2.1.
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Figure 2.1. Identification of the lactate tlireshold (^l)- The upper left panel 
shows identification of the based on the V-slope. Solid lines represent the sub 
- 0L and supra - slopes and the intersection point representing 6 .^ The upper 
right panel shows the conversion horn VO2  at the 6  ^to WR at the 6]^ . In all other 
panels the thick vertical dashed line represents 6  ^and the thin dotted line 
represents the respiratory compensation point.
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The VO2  identified at the was then converted to an equivalent WR as determined from 
the incremental test Vo2  to WR relationship. However, as an incremental ramp protocol 
was used, the VO2  response lags behind the steady state response for the associated WR. 
Therefore, to account for this lag an estimated 60s was used for the mean response time of 
the lag, and thus the WR at the desired VO2  was 15 W high (as the ramp was 15W/min) and 
this was subtracted from the determined WR.
2.4.2 Determination of the power-duration curve
There exists a hyperbolic relationship between the tolerable duration of high intensity 
constant load exercise and power output expressed by the equation:
W ’= (P -C P> t [1.7]
where W’ is the cui-vature constant, P the power output, CP is the critical power (of fatigue 
threshold) and t is the tolerable duration of exercise. (Moritani et al., 1981; Whipp et al., 
1982b; Poole et al., 1988). The plot of power versus time was linearised by plotting power 
versus l.time"\ the y-intercept (or power) then reflecting CP (Poole et al., 1988) (see 
section 1.3, Figure 1.2). The target WRs for the “ 6  minute” and “12 minute” tests for each 
subject were predicted from his power duration curve (Figure 2.2).
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Figure 2.2. Estimation of the WRs required for the “12 minute” and “ 6  minute” tests, for a 
single representative subject.
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2 .4.3 Modelling of the VO 2 kinetics
For each trial, ‘bad’ data points were removed as described above. In addition, data points 
lying outside a 99% prediction band (of a preliminary fit) were removed. Data were then 
interpolated to Is, time-aligned to the onset of the work rate (set to 0  sec), and similar 
protocols for each subject (5-6 repeats of moderate-intensity, two fatiguing tests to 
approximately six minutes of >CP, and two fatiguing tests to 12 minutes of >CP) were 
ensemble-averaged. The data were then averaged over 10s intervals.
The phase II component of the VO2  response was modelled to estimate the parameters of 
the response using a mono-exponential model (Whipp et ah, 1982; Paterson and Whipp, 
1991):
VO, (t)=A VO, (ss)+ VO, [1.8]
where VO2  (t) is VO2  at time t, A VO2  (ss) is the baseline VO2 , is the asymptotic value 
to which FO2  is assumed to project, t  is the time it takes to reach 63% of the response, and 
Ô is the time delay.
This was done with non-linear, least-squares regression technique using Origin software 
(Origin, Microcal Software, USA). The best fit was determined when the sum of square of 
errors (;>^ ) was not reduced with further iterations. The appropriate fitting ‘window’ for 
phase II was identified by:
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(a) Iteratively increasing the fitting window from 35s back towards Os until the t value 
increased, indicating inclusion of phase I data
and/or
(b) when the RER began to drop (due to slower FCO  ^ kinetics compared with ÊO3 
initially and therefore reflecting the point at which the muscle metabolic rate is 
being seen at the mouth) (Whipp and Ward, 1992).
The time taken to identify the start of phase II was taken as the 10s point after the 
occurrence of the above deteiminants. A fit was then performed from the identified 
beginning of the phase II to end of exercise at 6  minutes.
For the very heavy intensity exercise data, phase I was identified as described above and 
then a fitting ‘window’ from the start of phase II to initially 90s was used. To identify the 
start of the slow component, this ‘window’ was expanded iteratively towards end-exercise 
until the “goodness of the fit” deteriorated determined by three factors:
(a) the deviation of the residual plot deviated from the zero line;
(b) the attainment of a ‘threshold’ in the value (sum squared error) indicating a 
consistent deviation from the exponential fit;
(c) when the value of x began to systematically become larger.
A fit was then performed from the identified start of phase II to the 10s point before the 
occurrence of these determinants.
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The phase II amplitude for the VO2  response (An) was calculated as the change in VO2  
(l.min*^) for each step from baseline to the end of 6 minutes for moderate intensity exercise, 
and to the extrapolated phase II steady state for very heavy intensity exercise (figure x). 
The All was expressed relative to WR by dividing the An by the change in work rate 
(AWR); this is termed the gain (Gn). The amplitude of the slow component (Age) in the 
very heavy intensity exercise was calculated as the difference between the end exercise 
Vo2  (20s mean) and the identified Vo2  at the start of the slow component ( VO2  value taken 
from the end value of the phase II exponential fit) (Figure 2.3). Again, the slow component 
gain (Gsc) was given by Age/AWR. The rate of change for the slow component is calculated 
as the difference in A from minute 3 to minute 5 (20s mean) expressed as Asc 5-3 (Figure 
2.3).
60 Time (min)
■sc
Time (min)
Figure 2.3. Schematic representation of the VO2  kinetic parameters used in the present 
study for (a) moderate intensity exercise (b) very heavy intensity exercise.
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Total CK activity was determined at 25°C using a hexokinase/glucose-6 -phosphate 
dehydrogenase-coupled enzyme system, that ultimately yields a reduced nicotinamide 
diphosphate (NADPH) proportional to the total CK activity (Sigma Diagnostics, St. Louis, 
MO). A portion of the muscle biopsy was homogenized for 15 s in a 1:100 (wt/vol) 
dilution of CK extraction buffer containing 26mM Tris, 0.3M sucrose, 1% non-ionic 
detergent (NP-40) and 20mM mercaptoethanol at pH 8.0. Homogenates were then diluted
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2.4.4 Lactate
ILactate values represent an average of the two values obtained from each sample. The 
amplitude of the lactate increase was taken as the difference between the 20 W sample and 
the end-exercise sample.
2.4.5 Creatine Kinase
For quantification of the total creatine kinase (CK) activity the muscle protein was
extracted and placed in solutions of saturating substrate and enzyme concentrations so that 
the CK activity would be the rate limiting step. The maximal rate of CK activity was 
measured based on the production of nicotinamide diphosphate (NADPH) as it is 
proportional to the CK activity, this was done using (a) the absorbency of NADPH with 
spectrophotometery (b) the optical density of NADPH product on an electrophoresis gel. I■à:2.4.5.1 Total CK activity by spectophotometrv
■
 ;
to 1:100 in extraction buffer. Spectrophotometery was performed at 25°C with 1 ml of CK 
assay buffer. The assay buffer contained 130mM potassium choloride, lOmM Tris, ImM 
magnesium choloride, 2mM adenosine monophosphate (AMP), 50]uM diadenosine 
pentaphosphate (ADP), 5mM glucose, 0.7mM nicotinamide diphosphate, 1.5mM adenosine 
diphosphate, 9mM PCr, 1.3 units of hexokinase, and 0.5 units of glucose-6 -phosphate 
dehydrogenase at pH 7.4.
Spectrophotometry was performed using a Cecil 4400 double-beam spectrophotometer. 
Absorbance was measured at 340nm, and a baseline value obtained for the assay buffer was 
recorded and then 30 pi aliquots of diluted homogenate added to the assay buffer and 
mixed. The rate of absorbance, due to the production of NADPH through the coupled 
enzyme reaction, was obtained by measuring the absorbance each minute over five minutes. 
This rate, in arbitrary units of absorbance.min"% is proportional to the total CK activity.
2Â.5.2 CK isoform activity resolved electophoreticallv
Homogenized muscle tissue (as above) was centrifuged for 20 min at 14,000 
revolutions/min (4°C). The supernatant was diluted 1:10 in extraction buffer and 1 pi of 
diluted supernatant was added to a 1% agarose gel (Helena BioSciences, Europe). 
Electrophoresis was performed at 120 V for 20 min at 4°C. The MM, MB and BB isoforms 
are separated by this electrophoretic technique due to the different isoelectric properties of 
the isoforms. CK activity was visualised by spreading CK isoenzyme reagent (90mM
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phosphocreatine, 60 mM magnesium acetate, 60 m M glucose, 60 mM N-acetyl cysteine, 
15 mM AMP, 12 mM ADP. 6  mM NAD, 10 pM diadenosine pentaphosphate, 9000 U/1 
hexokinase and 7500 U/1 glucose-6 -phosphate dehydrogenase) on the gel and incubating 
for 20 min at 37°C. The production of NADPH in the gel was visualized using ultraviolet 
light. Photographs of the gels were taken using a digital camera (Nikon Coolpix 990) and 
analyzed by using a scanning densitometer program (Quantiscan, Biosoft, UK) to quantify 
the relative isoform activity.
2.4.6 Uncoupling protein mRNA expression
To resolve the UCP messenger ribonucleic acid (mRNA) expression the muscle mRNA 
was extracted, a complementary DNA strand was annealed to the mRNA and the product 
was amplified using reverse transcriptase polymerase chain reaction (RT-PCR). The PCR 
products were quantified relative to each other based on the optical density of the product 
from gel electrophoresis. The details of the procedures follow below.
a) Homogenization and extraction
A sample of the tissue was frozen in liquid nitrogen and then ground to a powder using 
pestle and mortar. The sample was mixed with denaturing solution for five minutes until it 
was dissolved. mRNA extraction was performed using the commercially available Tripure 
isolation reagent (Roche Diagnostics, Indianapolis, IN). This reagent disrupts cells and
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denatures endogenous nucleases thus preserving the integrity of deoxyribonucleic acid 
(DNA) and mRNA. 1 ml of Tripure was added to the homogenized tissue until it dissolved. 
The mixture was incubated at room temperature for five minutes, allowing dissociation of 
nucleoprotein complexes. To separate the mRNA from the organic phase and DNA, 0.2 ml 
of choloform was added to the mixture, shaken vigorously to 15s, left to incubate at room 
temperature for 2-15 minutes and centrifuged at 12 OOOg for 15 minutes at 4°C. The 
aqueous phase (containing the mRNA) was removed, mixed with 0.5 ml of isopropanol and 
left to incubate at room temperature for 5-10 minutes resulting in a precipitation of the 
mRNA from the aqueous layer. The mixture was centrifuged at 12 OOOg for 10 minutes at 
4°C after which the supernatant was removed and discarded. The mRNA pellet was washed 
(for purification) with 1ml of 75% ethanol after which the ethanol was poured off. The dry 
pellet was put on ice for 1 0  minutes and the pellet was re-suspended with nuclease free 
water heated to 60°C, allowing the mRNA to dissolve into solution form.
b) Spectrophotometry of mRNA
The absorbency of the samples at 260 nm was obtained using a spectTophotometer (Cecil 
4400 double-beam), allowing quantification of the amount of mRNA in the solution. Each 
sample was then diluted with nuclease free water to ensure the same concentration of 
mRNA between each sample analysed.
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c) Complementary DNA
Complementary DNA (cDNA) was made by mixing 5 pi with RNA with 2 pi of Oligo dT’s 
(12-18 bases long) (Amersham Biosciences, Piscataway, NJ). This mixture was incubated 
at 65°C for 5 minutes and then chilled on ice for longer than a minute, allowing for initial 
attachment to oligo dT to the RNA. To expand the cDNA strand on the RNA the following 
chemicals were added; a mixture of the four deoxynucleotide triphosphate (dNTP’s) (1 pi 
of each), 4 pi of first strand buffer, 1 pi of 0.1 M di-thio-threitol (DTT), 1 pi of RNAase out 
(which ensures no mRNA destroying RNAase is contaminating the sample) and 1 pi of 
superscript reverse transcriptase. The mixture was then incubated at 42°C for 5 minutes, 
50°C for 50 minutes and 70°C for 15 minutes. The cDNA was stored at -20°C until use.
d) Polymerase Chain Reaction
Reverse tianscriptase polymerase chain reaction (RT-PCR) was performed for the six tissue 
samples each with the following four primers added separately (i.e. 24 samples); PDK-4, 
UCP-3, UCP-2 and p-actin. To amplify the cDNA, 4 pi of cDNA was combined with 44 pi 
of a commercially available, pre made ‘reddy mix’ (ABgene, Surrey, UK), which was a 
mixture of Taq polymerase, dNTP’s, reaction buffers and magnesium choloride. This 
mixture was also combined with 1 pi of an antisense and 1 pi of sense primer (TAGN, 
Newcastle Upon Tyne, UK; sequences shown in Table 2.2), which were diluted in 2x the 
volume in nuclease free water, making a solution from the powder form.
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Primer Sense Antisense
UCP-3 AGAACCTCGCGAGGGAGGAAGGA CAGCGGGGAGGCCACTGT
UCP-2 GACCTATGCCTCATCAAGG ATAGGTGACGAACATCACCACG
PDK-4 CGGCTTGCCAATTTCTCGTCTGTA TGATCCCGTAAAGTGTCCTGAGTG
p-actin CCCAAGGCCAACCGCGAGAAGAT GTCCCGGCCAGCCAGGTCCAG
Table 2.2. Sense and antisense primer sequences used for RT-PCR.
Each of the end mixtures were therefore a reaction mixture of 50 pi. PCR cycles were 
then performed using an automated cycler (Darwin, Gene Legends, East Sussex, UK) with 
the following protocol; 5 minutes at 94°C, 35 repeats of (a) 30s at 94°C for denaturing 
(cDNA/RNA double strand opens to a single strand) (b) 30s at 57°C for annealing of the 
primers to the cDNA (c) 30s cycles of 45s at 72°C for extension of the template strand with 
the dNTP bases and finally 7 minutes at 72°C. PCR products were stored at -20*^ C until 
analysis.
e) Electrophoresis
An agarose gel was made using 40 ml of Ix tris-borate-EDTA (TBE) buffer (Promega, 
Madison, US) and 0.4 g of agarose. The mixture was boiled for one minute and allowed to 
cool. Ethidium bromide (0.4 pi) was added to the solution as it labels the PCR product.
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allowing visualisation under the ultra violet light later used for quantification. The solution 
was then added to a gel frame and allowed to set over night. 5 pi of each PCR product was 
mixed with 5 pi of the loading dye bromophenol, which allows visualization of the PCR 
product as it advances through the gel when electrophoresis is applied. The samples and a 
DNA ladder (providing a size reference) were added and loaded into the wells of the 
agarose gel. Electrophoresis was performed at lOOV until the products had advanced 2/3 of 
the way up the gel. The bands were visualized using ultraviolet light. Photographs of the 
gels were taken using a digital camera (Nikon Coolpix 990) and analyzed by using a 
scanning densitometer program (Quantiscan, Biosoft, UK) to quantify the relative intensity.
2.5 STATISTICAL ANALYSIS
Data are expressed as mean + standard deviation (SD). Tests to confirm that the data was 
noimally distributed were performed using the Ryan-Joiner test. Comparisons of results 
under different experimental conditions performed by each of the subjects were made by 
paired t-tests. Relationships between variables were examined using Pearson’s product- 
moment correlation. Statistical analyses were performed using Minitab (Minitab Inc., PA, 
US). Statistical significance was accepted at P < 0.05.
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CHAPTER 3
RESULTS
3.1 DEMARCATIONS OF EXERCISE INTENSITY
The demarcations of exercise intensity are (a) the lactate threshold ( 0 l) ,  which demarcates 
the moderate from the heavy intensity exercise domain; (b) the critical power (CP) or 
fatigue threshold, which demarcates the heavy from the very heavy intensity domain; (c) 
and VO2 peak, which demarcates the very heavy from the severe intensity exercise domain 
(see section 1.3 for details).
Above CP the tolerable duration of exercise decreased systematically with increasing work 
rate. As shown in the representative example (Figure 3.1), exercise duration decreased 
cuiwe linearly with increased WR, with this relationship being well fit by a hyperbolic 
function (Monod and Scherrer, 1965; Moritani et ah, 1981; Poole et ah, 1988). The power 
asymptote of this hyperbolic power-duration (WR-t) relationship or alternatively the y- 
intercept of the transformed W R-l/t linear regression, defines this work rate. In addition, 
the curvature constant of the hyperbola or the slope of the W R-l/t relationship represents 
that constant amount of work that can be performed above CP (W’). An example of a 
power duration curve and a power versus 1/time plot for a representative subject is shown
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in Figure 3.1. The WRs at each of the determined exercise intensities demarcations ( 0 l , CP 
and VO2  peak) can be found in section 2.1, Table 2.1. As 0 l and CP represent highly variable 
proportions of peak and WRpeak respectively (see section 1.3). Therefore, as well the CP 
is expressed as a percentage of the difference between the WR at 0 l and the WRpeak (AVA).
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Figure 3.1. The power-duration relationship for a single representative subject 
(subject 1) with three tests to the limit o f tolerance, (solid squares). The top panel 
shows the hyperbolic work rate versus time curve where the asymptotic value along 
the x-axis dashed line represents CP and the curvature constant equals W ’. The lower 
panel shows the power-duration relationship linearised as a function of 1/time. The 
intercept value on the work rate axis represents CP and the slope equals W \
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3.1.1 Moderate-intensity exercise
a) VO2  response kinetics
Following exercise onset, VO2  increases instantaneously while RER remains stable for 
~18s (Figure 3.2). RER then begins to drop and VO2  evidences a more marked increase. 
This transition point (arrow on Figure 3.2) represents the phase I-II transition (Whipp et al., 
1982).
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-10 10 20 
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Figure 3.2. Expanded display of RER (open circles) and VO2  (solid squares) following the 
onset of exercise (dashed line). A ito w s  indicated the identified start of the phase II 
response. Each point represents Is interpolated value (see methods, page 70).
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Phase II
VO2  then continues to increase as an exponential function with no discernible delay, to 
reach a new steady state within ~2-3 min; a corresponding decline was evident at the off- 
transient. A representative example of a complete VO2  -on-off-transieht response is shown 
in Figure 3.3, together with the best fit monoexponential to phase II (see methods, page 70, 
equation 1.8);
2.4 
2.2 
2.0 ■ 
1.8
"c 1.6 ■
I . .
1. 0 “
0.8: 
0.05 0.00 -0.05 •
boV .'
-180
V / \  r-\ A A A /" Ay V V w  ^  V V./
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m -.A f\
180 360
Time (s)
540 720
Figure 3.3. Averaged (10s) VO2  response (n=6), for an individual subject (subject 2), to a 
square wave change in WR. Dashed lines represents on onset and offset WR square-wave 
function. The residuals, shown in grey below the VO2  response, indicate the deviation of the 
fit from the actual response.
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i.e. the initial phase I components were excluded based on a (a) visual identification, (b) 
lengthening of the t estimate when phase I data points were included and (c) the RER 
profile (Figure 3.2).
What is clearly evident for this representative subject is that the residuals (a) scatter 
essentially randomly about zero (indicating a good fit to the model throughout the entire 
transient and (b) they are of small amplitude, i.e. < ± 0.05 l.min"  ^ compared to the 
amplitude of the VO2  response itself (< -3%  deviation in the on transient, < -2%  in the 
steady state).
b) Individual variability
Phase II
The gi'oup-mean parameter values for the VO2  kinetics to the moderate exercise are 
presented in Table 3.1. The mean on-transient phase II time constant ( th) was 21.2+3.7s, 
which was not significantly different from the mean off-transient th (25.3+5.Is). All 
subjects demonstrated this trend except one subject (subject 2) in whom the on-transient Tu 
was 19.0s and the off-transient Xn was 31.6s. However, we are confident in this response 
for subject 2 as (a) the th for each individual trial were similar to that of his averaged 
response; (b) the trend for a longer off-transient x was evident in every individual trial; and
(c) the fit of this subject was ‘good’, with a SD of only 0.5s and 0.6s for the on and off 
transients xn values respectively. The t\\ on value across subjects ranged from 16s to 25s.
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Because of the different WR amplitudes across subjects (reflecting their different 0 l values; 
Table 2,1), the corresponding steady-state change in Vo^  (A n ) varied between individuals, 
being higher when the work rate was higher. A n  on ranged from 0.5-1.41 l.min"  ^ and was 
not different to An off, which ranged fiom 0.51-1.43 l.m in'\ However, when An was 
normalized to WR (i.e. to provide the gain (G n )) the G n  on values were reasonably similar 
with a mean of 11.0+0.5 ml niin"  ^ W'% and were not significantly different from G n  off 
(mean= 10.8+0.7 ml.min'\W'^).
No relationship was found between Tu and VO2  peak (r=0.528, p=0.221) or between T\\ and 
0L(r=-0.215, p=0.682).
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3.1.2 Very heavy-intensity exercise
Above CP, a target of two repeat tests was selected this reflected necessary temporal 
constraints. However, it is important to emphasis that loss of statistical power resulting 
from a small “n” was likely to have been offset (to some extent) by the large amplitude of 
these supra-CP responses (Lamarra et al., 1987) (see section 4.5).
Despite the stringent criteria subjects followed so as to standardise conditions for testing 
(outlined in section 2.1) obtaining reproducible trials (in teims of tolerable duration) was 
difficult. This was perhaps not unexpected, given the challenging nature of these tests). In 
three cases (subject 2, 4, 5), only one trial for “12 minute” was used as the subjects were 
unable to perform a second trial with a time close enough to the first trial (i.e. differing by 
more than some 40 sec). This trend for “12 minute” to be less reliable than for shorter 
fatiguing tests has also been noted by Poole et al. (1988): these authors suggested that tests 
with a tolerable duration of ~8 min had increased variation (4-6%) compared to tests with a 
tolerable duration of ~4 min (2-4%). However, in the present study the VO2  response 
parameters could still be estimated with one trial i.e. with an acceptably small SD on the 
time constant.
In addition, the VO2  ee value was significantly lower for the “12 minute” test compared with 
“6 minute” test (3.89+0.55 and 4.00+0.52 respectively; p=0.014). The lower VO2  ee value 
was reached in the “12 minute” test despite randomisation of the tests, verbal
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encouragement, repeated attempts and subject exhaustion at a similar HR values (mean “12 
minute”= 184+10 bpm, “6 minute” =181+8 bpm). The values for VO2  ee are shown in Table 
3.2. Note that the inter-subject difference in VO2  ee ranged from 0.05 l.min'^ for subjects 1 
and 2 to 0.25 l.min'^ for subject 3.
S object C'O 2  e e  "6 m inute" (l .min b
V o  2 ee "12 minute" ^ ® = 
(i.m in’’ )
"6 m in ute  
(I.m in’
- 12  m inute" 
’ )
1 3 .6 3 3 . 5 8 0 . 05
2 4 . 8 0 4 . 7 5 0 . 0 5
3 3 . 57 3 . 33 0 . 2 5
4 4 , 43 4 . 3 2 0 . 12
5 3 . 55 3 . 46 0 .1 0
6 3 . 9 8 3 .8 8 0.1 1
Me a n 4 . 00 3 . 8 9 0.1 1
SD 0 . 52 0 . 55 0 .0 7
Table 3.2. VO2  ee values for the “12 minute” and “6 minute” tests and the difference 
between them.
The analytical goals of the supra-CP component of the project was to examine the 
proportional contributions of phase II and the slow component to the vial VO2  response at 
the two selected WRs. It was therefore decided to submit the “12 minute” data to a 
normalisation strategy, to facilitate comparison with the “6 minute” data (i.e. to account for 
the VO2  ee being slightly less in the “12 minute” tests). Thus, the “12 minute” data were 
expressed in terms of the actual response achieved and as a corrected value (A  ee cor). A  
schematic representation of the correction is shown in Figure 3.,4: the “12 minute” 
value is thus “extended” to the VO2  ee value for the “6 minute” test, allowing the amplitude
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components of the “12 minute” VO2  response to be expressed relative to the new Age value 
that would have occurred, had subjects actually achieved the “6 minute” on the “12
minute” test.
ee
correction
VO
126
Time (min)
Figure 3.4. Schematic representation of the correction for VO2  ee for the “12 minute” test. 
The “12 minute” VO2  ee is extended (indicated by the arrow) to that of the “6 minute”.
3.1.2.1 “12 minute” test
For the “12 minute” test, subjects cycled for a mean of 1 Imin 52 s± 40s. The mean A[La] 
at the end of the test was 8.510.8 mmol.l'\ Individual performance times and A[La] values 
are shown in Table 3.3,
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a) VO2  response kinetics 
Phase II
Similar to the moderate-intensity VO2  response profile, following phase I, the VO2  
increased as an exponential function. However, a new steady state is not reached within 
~2“3 min; rather, a slow component is superimposed on the phase II response, with VO2  
continuing to increase until Ko^ peak is reached (see section 1.3). A representative example 
is shown in Figure 3.5.
5 -,
4 -
3 -
oo°o‘oOO°o-o°o°oo‘^° o
120 240 360
Time (s)
480 600
Figure 3.5. Averaged (10s) VO2  response (n=l), for an individual subject (subject 2), to a 
square-wave increase in WR. The vertical dashed line represents on onset of WR, the solid 
line represents the fitting region and the extending dashed line represents the projection of 
that fit.
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The phase II response was modelled as a single exponential function (see section 2.4.3 for 
details) i.e. phase I and slow component were excluded (see section 2.4.3).
As described for moderate-intensity exercise (section 3.1.1, Figure 3.3) it is evident for this 
representative subject that (a) the residuals scatter apparently randomly about zero 
(although less so than shown for moderate-intensity exercise, indicating a slightly inferior 
fit) and (b) there is a small amplitude of the residuals e.g. < ± 0.15 l.min-1 when compared 
to the overall amplitude (< ~5% in the on tiansient, < ~4% in the steady state).
The mean phase II time constant (xn) was 26.9±10.3s. The phase II amplitude (An) was 
2.32 ±0.39 l.min'*: when expressed relative to the end-exercise amplitude (Age) the An 
contribution was 76.7+4.0%; and when expressed relative to WR, the phase II gain (Gn) 
was 9.8±0.3 ml.min'\W '^ The individual values are shown in Table 3.3.
Slow component
The increase in VO2  between (Age 5-3)  was 0.2910.06 l.m in'\ the slow component amplitude 
(Asc) was 0.7010.19 l.min-1 and the corrected slow component amplitude (Age cor) was
0.8110.16 l.min-1. Therefore, when expressed relative to Ace, Asc was 23.314.0% and Age 
cor was 27.214.9%. The slow component gain (Gsc) was 3.010.7 ml.min'^W'^ and the 
corrected slow component gain (Gsccor) was 3.51.7 ml.min'\W"\ The individual values are 
shown in Table 3.4.
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b) Individual variability 
Phase II
Tii ranged from 15.0 to 46.1 s. However, four of the subjects (subjects 1,2, 3,6) showed 
similar xn values (23-27s), whereas subject 4 had faster (15±0.8s) and subject 5 had slower 
(46.1+1.6s) values. A comparison between individuals shows that xn was not associated 
with Gn; i.e. subjects who had very similar x n values (subject 1 compared with 2, or subject 
2 compared with 6) showed a Gn difference of 0.4 ml.min-l.W '\ Similarly, subjects with 
very different Xu values (subject 4 compared with 5) also showed a difference of 0.4 
ml.min"\W"\ In addition, the xn values did not show a relationship with any indicators of 
the slow component response.
Furthermore, the exercise-induced increase in blood [lactate] (A[La]) was not associated 
with the phase II VO2  response parameters. For example subjects 4 and 5 had very 
different xn values and also different A[La] values; subjects 4 and 3 also had different xn 
values, but similar A[La]; and subjects 2 and 6 had very similar xn values but appreciably 
different A[La] values.
Slow component
Subject 4 (with a fast xn) showed a smaller % Age cor, Gsc and Agc5-3 compared to subject 5 
(slower xii). In contrast, there were subjects who had very similar Xn values i.e. subject 1
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compared with 3 or 2 compared with 6 but appreciably different % Age cor-, Ggc and Age 5-3 
(although Age 5-3 was not different for subjects 1 and 3).
A[La] also was not associated with any of the slow component indicators. Although A[La] 
was lower in subject 4 compared with subject 5, Age as % Age was similar. Likewise, for 
subject 3 compared with 4, Age as % Aee was appreciably different but A[La] was similar. 
For Gsc, subjects 3 and 4 showed different values but similar A[La] values, while subjects 3 
and 5 had similar Ggc values but appreciably different A[La] values. Finally, although Agg 5. 
3 was very different between subjects 1 and 2, A[La] was similar; conversely subjects 4 and 
6 had similar Agg 5.3 values, but very different A[La] values.
Therefore, the individual variability in Vo2  response parameters for the “12 minute” test 
did not demonstrate any overall trends or relationships between each other or with A[La].
c) Comparison to moderate-intensity exercise
The “12 minute” xn (26.9±10.3s) was not statistically different from that for moderate- 
exercise (21.3±3.7s, p=0.150). However, it can be seen in Figure 3.6 that there was a trend 
for the “12 minute” Xn to be slightly slower than the moderate Xn in 3 subjects (subjects 
2,3,5) and appreciably slower in subject 6.
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Figure 3.6. r\\ values for “12 minute” compared with moderate-intensity exercise.
The Gii for moderate intensity exercise (11.0+0.4 ml.min'^W'^) was significantly greater 
than that for the “12 minute” test (9.8+0.2 ml.min p=0.001) in all subjects as shown
in Figure 3.7.
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Figure 3.7. Gain for “12 minute” compared with moderate-intensity exercise.
3.2.2.2 “6 minute” test
For the “6 minute” test, subjects cycled for a mean of 6 min 8s ±53s. The mean A[La] was 
7.9+1.2 mmol.F\  Individual performance times and A[La] values are shown in Table 3.5.
a) V o 2 response profile
Phase II
As described for the “12 minute” test, following the phase I, the VO2  increased as an 
exponential function. The slow component is superimposed on the phase II response, with
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Vo^  continuing to increase until FO^ peak is reached (see section 1.3). A representative 
example is shown in Figure 3.8.
5-1
4 -
3 -
1
0.1 d  0.0 -  
- 0.1  -
.Z_
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60 0 60 120 180 240 300
Time (s)
Figure 3.8. Averaged (10s) VO2  response (n=2), for an individual subject (subject 2), to a 
square-wave increase in WR. The dashed line represents on onset of WR, the solid line 
represents the fitting region and the extending dashed line represents the projection of that 
fit. The residuals, shown in grey below the VO2  response, indicate the deviation of the fit 
from the actual response.
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The phase II response was modelled as a single exponential function (see section 2,4.3 for 
details) i.e. phase I and the slow component were excluded (see section 2.4.3).
It is evident for this representative subject that (a) the residuals scatter apparently randomly 
about zero (although less so than shown for moderate intensity exercise, indicating a 
slightly inferior fit) and (b) there is a small amplitude of the residuals e.g. < ± 0.10 l.min'* 
when compared to the overall amplitude (< ~3% in the on transient, < -2.5% in the steady 
state).
The mean t was 29.3+9.2 s. An averaged 2.52+0.36 l.min'*: when expressed relative to A 
ee the An contribution was 79.8+3.4%; and when expressed relative to WR Gn was 9.7+0.6 
ml.min"\W"'. The individual values are shown in Table 3.5.
Slow component
The mean Age 5-3 was 0.38+0.15 l.min'^ and Age was 0.65+0.20 l.m in'\ Therefore when 
expressed relative to Age, Age was 20.2+3.4% and when expressed relative to WR, Ggg was 
2.6+0.5 ml.min'\W "\ Individual values are shown in Table 3.6.
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b) Individual variability 
Phase II
Tu ranged from 17.4 to 45.7 s. However, four of the subjects (subjects 1,2, 3,6) showed 
similar th values (27-29s), whereas subject 4 and 5 had faster (17+0.4s) and slower 
(46.1+0.6s) values, respectively. A comparison between individuals shows that Tn was not 
associated with Gn; i.e. subjects who had very similar Tn values (subjects 2  compared with 
3) showed a Gn difference of 0.9 m l.m in '\W '\ whereas, subjects with very different Tn 
(subjects 4 compared with 5) showed a difference of only 0.4 ml.m in-l.W '\ In addition, 
the Tn values did not show a relationship with any indicators of the slow component 
response. Furthermore, A[La] was not associated with the phase II response 
parameters. For example subjects 4 and 5 had very different Tn values and also different 
A[La] values; subjects 2 and 6  had very similar A[La] values but appreciably different Tn 
values.
Slow component
Subject 4 and 5 had very different Tn values but similar Age as % Age, Ggc and Agg 5-3 values. 
In contrast, subjects 2 and 6 had very similar Tn values but appreciably different % Age cor-, 
Ggc and Age 5-3 values.
A[La] was also not associated with any of the slow component indicators. Although A[La] 
was higher in subject 4 compared with subject 6 , Age as % Age was very similar. Likewise,
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for subjects 1 compared with 2, Age as % Age was appreciably different but A[La] was 
similar. For Ggg subjects 1 and 2 showed different values but similar A[La] values while 
subjects 2 and 4 had similar Ggg values but appreciably different A[La] values. Finally, 
although Age 5.3 was very different between subjects 1 and 2, A[La] was similar; conversely, 
subjects 4 and 6 had similar Agg 5.3 values but very different A[La] values.
Therefore, as found for the “12 minute” test, the individual variability in the VO2  response 
parameters for the “6 minute” test did not demonstrate any overall trends or relationships 
between each other or with A[La].
c) Comparison to moderate-intensity
The Tii (29.3±9.2s; p=0.033) was slower compared with moderate intensity (21.3+3.7 s) for 
all subjects, as shown in Figure 3.9.
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Figure 3.9. Tu value for “6 minute” compared with moderate intensity exercise.
Gii for moderate intensity exercise (11.0+0.4 ml min'^ W'^) was significantly greater than 
“6 minute” for all subjects (mean =9.7±0.6 ml min“^ p<0.0001), as shown in Figure 
3.10.
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Figure 3.10. Gn for “6 minute” compared with moderate-intensity exercise
3.1.2.3 Comparison of “12 minute”and “6 minute” tests
a) [Lactate]
The [La] at rest, 20W, and end-exercise were not significantly different between the “6 
minute” and “12 minute” tests. Mean values are shown in Table 3.7.
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[La] for “12 minute” 
(mmol.min'^)
[La] for “6 minute” 
(mmol.miif^)
Rest 1.21+0.29 1.11+0.22
20w 1.26 + 0.30 1.33 + 0.20
End exercise 9.11 + 1.12 9.82 +0.95
Table 3.7. [La] at rest, 20w and end exercise for “6 minute” and “12 minute” tests.
Therefore, the A[La] from 20w to end exercise was not significantly different the tests (“6 
minute” 7.85+1.20, “12 minute” 8.50+0.82). Individual values for A[La] are shown in 
Table 3.3 and 3.5.
b) Temporal parameters 
Phase II
The phase II fitting window, discerned hom the criteria outlined in chapter 2, resulted in a 
mean fitting window ranging from 25 to 154 s for the “12 minute” test, and from 25 to 127s 
for the “6 minute” test. T\\ was faster for “12 minute” than for “6 minute” (26.9+10.3 and 
29.3+9.16, respectively), as shown in Figure 3.11. Although the mean difference was only 
2 seconds, the trend was seen in all but one subject (subject 5) and was therefore 
statistically significant (p=0.03).
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Figure 3.11. t\\ value for “6 minute” compared with “12 minute”
Slow component
The rate of increase of the slow component, demonstrated by the index Asc 5-3 , was similar 
(p=0.203) for the “12 minute” test (0.29+0.06 l.min'^) and the “6 minute” test (0.38±0.15 
l.min'^) (Figure 3.12). However, 3 of the subjects (4, 5, 6) showed slightly greater Age 5-3 
for the “6 minute” test and subject 2 showed an appreciably greater Age 5-3 .
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Figure 3,12. Asc 5-3 for “6 minute” compared with “12 minute’
c) Amplitude and gain parameters 
Phase II
As expected (i.e. as the WR is lower), An was significantly less for the “12 minute” 
compared with the “6 minute” test (2.32+0.39 and 2.52+0.36, respectively; p=0.000). 
However, the magnitude of this difference varied between subjects: subject 2 showed a 
small difference (0.18 l.min'^), whereas subject 3 showed a larger difference (0.32 l.min'^). 
The relationship between the “6 minute” -  “12 minute” difference in An and Vo2  ee (Figure 
3.13) demonstrated a significant correlation (r=0.914, p-0.03).
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Figure 3.13. Relationship between “6 minute” -”12 minute” difference in An and Aee-
This correlation is further illustrated by the VO2  responses to the “12 minute” and “6 
minute” tests for individual subjects. A subject who reached a similar VO2  ee (subject 2) is 
shown for the “6 minute” and “12 minute” is shown, demonstrating that the An was also 
similar (Figure 3.14). In contrast a subject (subject 3) who did not reach a similar 
during the “12 minute” similar to that for the “6 minute” is also shown, demonstrating that 
An was appreciably different (Figure 3.15).
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Figure 3.14. VO2  profiles for the ”12 minute” and “6 minute” tests for subject 2, who 
reached similar A ee values for the “12 minute” and “6 minute” tests. Solid circle indicates 
“6 minute” data, open square indicates “12 minute” data.
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Figure 3.15. VO2  profiles for the “12 minute” and “ 6  minute” tests for subject 3, who did 
not reach a similar A ee values for the “12 minute” and “ 6  minute” tests. Solid circle 
indicates “ 6  minute” data, open square indicates “ 1 2  minute” data.
As All was similar for “12 minute” and “ 6  minute2 in subject 2, when expressed relative to 
WR the G ii was lower for the “6  minute” test compared with “12 minute” (i.e. An 
normalised for WR). In subject 3, An was much higher for the “ 6  minute” test compared 
with “ 1 2  minute”, and therefore Gn was larger for “ 6  minute” compared with “ 1 2  minute”. 
However, there was no significant difference between G n for the two tests with mean G n  
being similar for the “12 minute” and “ 6  minute” trials (9.8+0.2 and 9.7±0.6, respectively). 
Individual data are shown in Figure 3.16.
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Figure 3.16. Gn for “ 6  minute” compared with Gn for “12 minute”.
Slow component
Asc for the “12 minute” and the “ 6  minute” tests were similar (0.70+0.19 and 0.64+0.20
l.min-1, respectively, p=0.129) (Figure 3.17). However, Asc cor for the “12 minute” test was 
significantly greater than that for the “ 6  minute” test (0.81+0.16 and 0.65+0.20 l.min-1 , 
respectively; p=0.004) (Figure 3.18).
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Figure 3.18. Ago “ 6  minute” compared with Age cor “12 minute”.
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Similarly, Gsc cor for the “12 minute” test was significantly greater than that for the “ 6  
minute” test (p=0.035) as shown in Figure 3.19.
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Figure 3.19. Gsc “ 6  minute” compared with Ggc cor “12 minute”.
Proportional contribution o f phase II and the slow component
To compare the amplitude profiles of each of the components of the “12 minute” and “ 6  
minute” response, the data have been expressed as percentages of the conesponding end- 
exercise amplitude (Age) obtained from each of the tests. The slow component amplitude at 
end-exercise was therefore 23.3% and 20.4% of the total Ace for the “12 minute” and “ 6  
minute” tests, respectively; with the phase II amplitude of the “12 minute” test was only
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being 76.7% and 79.6%, respectively. Following ‘correction’, the phase II amplitude of the 
“12 minute” test was only 74.0% while the slow component increased to 26%. This 
comparison is shown in Table 3.8.
An (%) Asc (%)
“12 minute” “6 minute” “12 minute” “12 minute”
Actual value 76.7 79 .6 23.3 20 .4
Conected value 74.0 7 9 .6 2 6 .0 20 .4
Table 3.8. Comparison between the mean proportional contribution of An and Asc for “12 
minute” and “ 6  minute”. Expressed as ‘actual’ values and as the ‘corrected values’ for the 
“ 1 2  minute” data.
3.2 RELATIONSHIP BETWEEN CREATINE KINASE AND VO^  KINETICS
What controls VO2  kinetics during exercise remains to be elucidated. However, evidence 
has suggested a relationship between the intramuscular PCr status (or some surrogate of 
this) and VO2  (see section 1.5.1.3). Therefore, intramuscular (vastus lateralis) CK activity 
rates, were measured to determine whether there was a relationship between CK activity 
and Vo2  kinetics.
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3.2.1 Creatine kinase activity
To increase the reliability of the total CK activity measured from spectrophotometry, the 
absorbency rate at two concentrations of homogenate was performed. A proportional 
increase in the CK activity rate at the higher concentration of homogenate (30 pi of non­
diluted homogenate) occuiTed for all subjects, indicating good reliability.
The relationship between the absorbency rate at 300 pi of diluted homogenate and 30 pi of 
non-diluted homogenate, for each subject, is shown in Figure 3.20.
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Figure 3.20. Relationship between CK activity with 300 pi of diluted (1:100) homogenate 
and 30 pi of non-diluted homogenate.
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As 30 pi of non-diluted homogenate was the more-concentrated solution, it was used for 
the expression of CK activity rates by spectrophotometry. These values ranged from 11.4 
to 32.6 absorbance.min’*.
The isoform distribution of CK resolved using electrophoresis showed a predominance of 
CK-MM activity in all subjects, with undetectable levels of the other isoforms (Figure
3.21). That is, the CK-MM activity (e.g. Figure 3.21) was essentially entirely reflective of 
total CK activity levels. With electrophoresis, the CK activity ranged from 2.38 to 3.11 
O.D.
Figure 3.21. Picture of the electrophoresis gel, showing the absorbency of NADPH, a 
marker of CK activity. Lane 2-7 represents the optical density for each subject. Lane 1 
served as a control as it was from the same subject as that in lane 2 and had the same 
optical density.
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3.2.2 Creatine kinase activity and moderate-intensity exercise
a) Temporal parameters 
Phase II
The CK activity level based on specti'ophotometiy and the phase II time constant (t) 
values for moderate intensity exercise showed no correlation (r=0.027; p=0.959) (Figure
3.22).
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Figure 3.22, Relationship between CK activity rates from spectrophotometery and t\\ for 
moderate intensity exercise. Arrow indicates possible outlier.
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However, it is apparent that an outlier (indicated by the arrow) may have skewed, an 
otherwise trend towards a of lower CK activity being associated with a faster
This trend became statistically significant when CK activity was resolved with 
electrophoresis, the CK-MM activity showed a significant correlation with tr for (r=0.964, 
p=0.002) (Figure 3.23).
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Figure 3.23. Relationship between CK activity from electrophoresis and tn for moderate 
intensity exercise.
With spectrophotometry, normalisation for protein concentrations is done relative to the 
weight of the whole muscle tissue, which includes connective tissue (whereas CK is only in
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ill
skeletal muscle protein). Therefore, if a particular muscle sample contains a large amount 
of connective tissue compared with other samples, then the CK level could appear lower 
than it should be, i.e. it would have been normalised ‘excessively’ for the actual amount of 
muscle protein in the sample. With electrophoresis, however, only the supernatant is used 
(i.e. free of connective tissue). And thus, as subject 1 showed a significantly lower CK 
activity with spectrophotometry compared to electrophoresis, it was decided to characterise 
the CK activity profiles using only the electrophoresis measurements; ensuring that CK 
expression was noimalised to the appropriate protein concentration for all subjects.
b) Amplitude and gain parameters 
Phase II
However, no relationship was found between CK activity and the phase II gain (Gn) for 
moderate-intensity exercise (r=0.133, p=0.801) as shown in Figure 3.24.
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Figure 3.24. Relationship between CK activity and Gnfor moderate intensity exercise.
3.2.3 Creatine kinase activity and very heavy-intensity exercise
a) Temporal parameters 
Phase II
Similar to moderate-intensity exercise, a trend towards lower CK activity with a faster Xn 
was evident, However, the strength of this relationship was less than that for moderate- 
intensity exercise, i.e. no significant correlation was found between CK activity and xn for
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the 12 minute test (Figure 3.25) or the 6  minute test (Figure 3.26) (“12 minute” r=0.423, 
p=0.403; “ 6  minute” r=0.525, p=0.285).
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Figure 3.25. Relationship between CK activity and T for “12 minute”
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Figure 3.26. Relationship between CK activity and Tu for “ 6  minute”
R/ow component
The CK activity was not associated with the rate of slow component increase (Age 5.3) for 
“12 minute” as shown in Figure 3.27 (i--0.003, p=0.995). And although a positive trend 
was observed in the corresponding relationship for he “ 6  minute” test, this was not 
significant (r=-0.396, p=0.436) (Figure 3.28).
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Figure 3.27. Relationship between CK activity (with electrophoresis) and Agcs-s for “12 
minute”.
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Figure 3.28. Relationship between CK activity and Age5-3 for “ 6  minute’
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c) Amplitude and gain parameters 
Phase II
A  significant positive relationship was found between CK activity and the phase II gain 
(Gii) for the “12 minute” test (r=0.957, p=0.003), as shown in Figure 3.29. A similar trend 
was evident for the “ 6  minute” test, but this was not significant (r=0.567, p=0,241) as 
shown in Figure 3.30.
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Figure 3.29. Relationship between CK activity and Gn for “12 minute’
127
3.2 n
.3.0
2 .8 -
8cIcc
è^.6-
1
 1—
8.8 9.0
1------ '------ 1------ '------ r
9.2 9.4 9.6 9.8 10.0 10.2 10.4
"6 minute" (ml.min-fW-i)
Figure 3.30. Relationship between CK activity and Ou for “ 6  minute”.
Slow component
A negative trend was evident between CK activity and the slow component amplitude (Age) 
for “ 6  minute”; however it was not significant (i--0.519, p=0.302) as shown in Figure 3.31, 
In contrast, the slow component gain (Ggc) showed an essentially significant trend with CK 
activity (r=-0.810, p=0.051; shown in Figure 3.32); i.e. an increased CK activity was 
associated with a smaller Ggc-
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Figure 3.31. Relationship between CK activity and Age for “ 6  minute”.
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Figure 3.32. Relationship between CK activity and Ggc for “ 6  minute”.
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3.2.4 Creatine kinase activity and fitness level
No relationship was found between CK activity and any indicator of fitness level; 0l (r=- 
0.194, p=0.206; Figure 3.33), CP (r=-0.542, p=0.266; Figure 3.34), W’ (i-G.775, p=0.103; 
Figure 3.35) and Vo^  peak (r=-0.560, p=0.247; Figure 3.36). However, there was a 
negative trend between CK activity and W’.
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Figure 3.33. Relationship between CK activity with electrophoresis and the lacate 
threshold.
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Figure 3.34. Relationship between CK activity with electiophoresis and critical power.
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Figure 3.35. Relationship between CK activity with electrophoresis and anaerobic work 
capacity (W’).
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Figure 3.36, Relationship between CK activity and VO 2 peak
3.3 RELATIONSHIP BETWEEN UNCOUPLING PROTIENS AND VO^  
KINETICS
The mechanism responsible for the VO2  slow component at above 6l remains to be 
elucidated. However it was recently suggested that expression of UCP-3 (but not UCP-2) 
might be involved. Therefore, the present study measured UCP-2 and UCP-3 mRNA 
expression in the vastus lateralis muscle sampled to determine whether a relationship 
between UCP and the slow component exists when appropriate modelling and 
quantification of the slow component is used (see page 169 for discussion). In addition, as
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the mechanisms responsible for other VO2  kinetic parameters was unknown, their 
relationship with UCP has also been investigated.
As the VO2  ee value for the “12 minute” test was lower than that for the “ 6  minute” test (see 
section 3.1.2), for the purposes of correlating the slow component with the expression of 
UCP-2 and UCP-3, only the slow component data for the “ 6  minute” test were used, i.e. 
ensuring that only a ti'ue slow component amplitude is used in analysis.
3.3.1 Uncoupling protein mRNA expression
The photograph of the gel, for the intensity of UCP-3, pyruvate dehydrogenase kinase 
(PDK), /5-actin and UCP-2 of each individual, is shown in Figure 3.37.
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Figure 3.37. Polymerase chain reaction products on the electrophoresis gel. Lane 1 top and 
bottom are DNA ladders; lane 2, bottom is a control; lane 2-8, top are UCP-2; lane 9-13, 
bottom are PDK, lane 3-8, bottom are /3-actin; lane 9-14, bottom are UCP-3 expression.
The expression of PDK-4 (indicator of mitochondrial content) was minimal-to- 
undetectable in most subjects. As the PCR worked for the other primers this low level of 
expression is probably due to the quality of the primer or the amount of magnesium 
required for PDK-4 primer annealing is greater than that of the other primers. Therefore, 
UCP-2 and UCP-3 are expressed relative to a “house keeping” gene i.e. p-actin. It was 
found that the UCP-3 mRNA expression ranged from 1.227 to 2.955 O.D. units 
(mean= 1.802+0.683 O.D.). For UCP-2 mRNA expression, one subject showed 
undetectable levels of UCP-2 mRNA; therefore, this subject (subject 6) was excluded from 
the analysis of UCP-2. Reasons for this response are unknown. The UCP-2 expression for
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the remaining five subjects ranged fi'om 2.234 to 5.412 O.D. units (mean-3.571+1.278 
O.D.). As only five subjects were available for UCP-2 analysis, the results should be 
interpreted with even greater caution.
3.3.2 Uncoupling protein expression and moderate-intensity exercise
a) Temporal parameters 
Phase II
No significant relationship was found between UCP-3 and the phase II time constant (xn) 
(r=0.044, p=0.934), although a positive trend (but non-significant) was evident in the case 
of UCP-2 (r=0.709, p=0.180) as shown in Figure 3.38.
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Figure 3.38. Relationship between xn for moderate intensity exercise and UCP-3 (open 
circle) and UCP-2 (solid square). Five subjects for UCP-2 and six subjects for UCP-3 
shown.
a) Amplitude and gain parameters
No significant relationship was found between either UCP-2 or UCP-3 and the phase II 
gain ( G i i )  (UCP-2 r=0.251, p=0.684; UCP-2=0.713, p=0.112) as shown in Figure 3.39.
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Figure 3.39. Relationship between Gn for moderate intensity exercise and UCP-3 (open 
circle) and UCP-2 (solid square). Five subjects for UCP-2 and six subjects for UCP-3 
shown.
3.3.3 Uncoupling protein and very heavy-intensity exercise
a) Temporal parameters 
Phase II
No relationship was evident for UCP-2 or UCP-3 and phase II time constant (xn) for “12 
minute” as shown in Figure 3.40 (UCP-2 r=0.643, p=0.242; UCP-3 r=0.074, p=0.889) or “ 6  
minute” as shown in Figure 3.41 (UCP-2 r=0.643, p=0.242; UCP-3 r=0.297, p=0.568).
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Figure 3.40. Relationship between tn for “12 minute” and UCP-2 (solid square) and UCP- 
3 (open circle). Five subjects for UCP-2 and six subjects for UCP-3 shown.
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Figure 3.41. Relationship between xn for “ 6  minute” and UCP-2 (solid square) and UCP-3 
(open circle). Five subjects for UCP-2 and six subjects for UCP-3 shown.
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Slow component
No correlation was found between UCP-3 and the rate of the slow component increase 
(Asc5-3) for “12 minute” (i~-0.071, p=0.894; shown in Figure 3.42) or Ascs-3 for “ 6  minute” 
(r=-0.321, p=0.535, shown in Figure 3.43). However, a non significant negative trend was 
evident for UCP-2 and Asc 5-3 for “12 minute” (i--0.353, p=0.560) as shown in Figure 
3.42, and an even stionger trend was evident between UCP-2 and Asc 5-3 for “ 6  minute” as 
shown in Figure 3.43 (UCP-2, r=-0.870, p=0.055)
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Figure 3.42. Relationship between Age 5-3 for “12 minute” and UCP-2 (solid square) and 
UCP-3 (open circle). Five subjects for UCP-2 and six subjects for UCP-3 shown.
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Figure 3.43. Relationship between Asc 5-3 for “ 6  minute” and UCP-2 (solid squares) and 
UCP-3 (open circles). Five subjects for UCP-2 and six subjects for UCP-3 shown.
b) Amplitude and gain parameters
Phase II
No relationship was found between UCP-3 and Gn for “12 minute” (r=0.074, p=0,889; 
shown in Figure 3.44) or “ 6  minute” (i-0.297, p=0.568; shown in Figure 3.45). A slight 
but non-significant positive trend was evident between UCP-2 and Gn for “12 minute” 
(r=0.643, p=0.242; shown in Figure 3.44) and “ 6  minute” (r=0.512, p=0.242; shown in 
Figure 3.45).
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Figure 3.44. Relationship between Gn for “12 minute” and UCP-2 (solid squares) and 
UCP-3 (open circles). Five subjects for UCP-2 and six subjects for UCP-3 shown.
5.5 -
5.0
4.5 -
4.0 -
3.5 -
3.0 -
2.5 -
2.0  -
1.5 -  
1.0
8.8 9.0 9.2 9.4 9.6 — I- - - - - - - - - - ' - - - - - - - - - - 1- - - - - - - - - - ' - - - - - - - - - - 1- - - - - - - - - - - - ' - - - - - - - - 1—9.8 10.0 10.2 10.4
"6 minute" (ml.min-i.W-i)
Figure 3.45. Relationship between Gn for “12 minute” and UCP-2 (solid squares) and 
UCP-3 (open circles). Five subjects for UCP-2 and six subjects for UCP-3 shown.
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Slow component
No significant relationship was found between UCP-3 and the end-exercise slow 
component amplitude (Asc) as shown in Figure 3.46 (UCP-3, 1--0.283, p=0.587). There 
was however, the suggestion of a negative trend between UCP-2 expression and Asc as 
shown in Figure 3.46; however, this was not significant (UCP-2, r=-0.822 p=0.088).
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Figure 3.46. Relationship between UCP-2 (solid squares) and UCP-3 (open circles) and 
Asc for “ 6  minute”. Five subjects for UCP-2 and six subjects for UCP-3 shown.
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No relationship was found between UCP -3 and Gsc for “ 6  minute” (i—-0.288, p=0.580) as 
shown in Figure 3.47. Again, a negative trend was evident for UCP-2; however, this was 
not significant (r=-0.868, p=0.056) as shown in Figure 3.47.
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Figure 3.47. Relationship between UCP-2 (solid squares) and UCP-3 (open circles) and 
Gsc for “12 minute”. Five subjects for UCP-2 and six subjects for UCP-3 shown.
3.3.4 Uncoupling protein expression and fitness levels
A significant relationship was found between UCP-2 and W’ (i-= -0.918, p=0.028; Figure
3.50). However, UCP-3 and UCP-2 were not correlated with any of the other indicators of 
fitness Ol; (UCP-3 r=-0.075, p=0.888; UCP-2 r=-0.643, p=0.242; Figure 3.48), CP (UCP-3
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r-0.301, p-0.562; UCP-2 r=-0.643, p=0.242; Figure 3.49), W(UCP-3 r=-0.025, p=0.96; 
Figure 3.50) and Vo2  peak (UCP-3 r=0.029, p=0.956; UCP-2 r=0.695, p=0.395; Figure
3.51).
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Figure 3.48. Relationship between UCP -2  (solid square) and UCP-3 (open circle) and the 
lactate threshold. Five subjects for UCP-2 and six subjects for UCP-3 shown.
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Figure 3.49. Relationship between UCP -2  (solid square) and UCP-3 (open circle) and 
critical power Five subjects for UCP-2 and six subjects for UCP-3 shown
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Figure 3.50. Relationship between UCP -2  (solid square) and UCP-3 (open circle) and W’. 
Five subjects for UCP-2 and six subjects for UCP-3 shown.
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Figure 3.51. Relationship between UCP -2  (solid square) and UCP-3 (open circle) and VO 
2 peak. Five subjects for UCP-2 and six subjects for UCP-3 shown.
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CHAPTER 4 
DISCUSSION
4.1 INTRODUCTION
The control of VO2  kinetics during exercise remains inconclusive. However, the 
demonstration of a close matching between the kinetics of phosphocreatine (PCr) 
breakdown and VO2  increase at the exercise onset (and the converse at exercise offset) 
provides compelling evidence that the control processes reside within the muscle and 
involve some aspect of high-energy phosphate turnover (Mahler, 1985; Rossiter et ah, 
1999). It has also been suggested that the mechanisms controlling VO2  kinetics are 
intensity-dependent, with O2 delivery asserting a greater role during heavy-intensity 
exercise (e.g. Grassi et ah, 2000). During exercise performed above the lactate threshold 
(O l)  an additional delayed component of ‘excess’ VO2  is manifest (the ‘slow component’)
the mechanism of which remains to be elucidated. In addition, the VO2  kinetic parameters 
during very heavy-intensity exercise (above critical power) have not been investigated 
using the most appropriate modelling procedures.
Therefore, the main objectives of the present study were to investigate: (1) the relationship 
between creatine kinase (CK) and VO2  kinetics during moderate- and very heavy-intensity
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exercise; (2) the VO2  kinetics to repeats at two different exhausting WRs in the very heavy- 
intensity exercise domain, placing emphasis on the degree of inter-subject variability; (3) 
the relationship between uncoupling protein expression and the VO2  slow component of 
very heavy-intensity exercise.
4.2 MODERATE INTENSITY EXERCISE
4.2.1 Phase II
4.2. LI Temporal parameters
The results from the present study for VO2  kinetics in the moderate-intensity exercise 
domain are consistent with previous investigations on cycle ergometry. It has been shown 
that the on-transient phase II time constant (tn) for young healthy subjects averages 
approximately 25-30 s (e.g. Whipp et al., 1982; Hughson et al., 1988; Paterson and Whipp, 
1991; Whipp and Ozyener, 1998; Ozyener et al., 2001). In the present study, the in ranged 
from 16 s to 25s across subjects, and the faster than average VO2  kinetics is consistent with 
the aerobic fitness levels being in the “above average to fit” range (i.e. FOppeak ranging 
from 45.3 to 56.1 ml.kg"\min"^). In addition, consistent with the literature, the o ff transient 
Tii was not different to the on-transient tn (Linnarsson, 1974; Whipp et al., 1982; Griffiths 
et al., 1986; Paterson and Whipp, 1991; Ozyener et a l, 2001).
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Creatine kinase
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Despite the narrow range of th values in moderate-intensity exercise a significant and
.negative correlation was found between xn and vastus lateralis CK activity (section 3.2.2,
Figure 3.23). Evidence in the literature regarding the role of CK activity in oxidative 
phosphorylation is confounding, with many suggestions leading to different hypothesis of 
how CK activity might influence muscle QO  ^ and hence VO2  in the exercise on-transient. 
Roman et al. (1996) demonstiated in mice that, when skeletal muscle CK activity was 
increased by 47% there was no difference in the rate of PCr breakdown (using ^*P-NMR 
spectroscopy) at the onset of twitch contractions, compared to control mice. This would 
suggest that the control level of CK activity was in excess of the noimal metabolic rate; 
otherwise, the rate of PCr breakdown would have been faster as a result of the increased 
activity. Based on these findings, the present investigations in humans might have been 
expected to reveal no correlation between CK activity and xn. At odds with this view are 
the demonstrations in the horse, which have reported a speeding of VO2  kinetics when 
nitric oxide, a putative inhibitor of CK (Brown et al., 2000), is inhibited by L-NAME 
administration (Kindig et al., 2001, 2002a). This would suggest a faster xn would be 
associated with an increased CK activity (at least in the horse).
More recently, however, Roman et al. (2002) used ^^P-NMR spectroscopy with an 
increased time resolution compared to that they had used previously (Roman et al., 1996) 
and showed that at the onset of twitch stimulation slower PCr breakdown occurred in CK-
deficient mice. Recognising that [ADP] is a candidate controller of mitochondrial 
oxidative phosphorylation (e.g. Jeneson et al., 1996; Conley et al., 2001) these authors used 
modelling techniques to predict the influence of the CK-knockout paradigm on [ADP] 
kinetics and therefore QO ,^. That is, in the CK-deficient condition, muscle [ADP] cannot 
be calculated from the assumed equilibrium of CK-catalysed PCr hydrolysis. It was of 
interest, therefore, that the model predicted a dissociation of [PCr] and [ADP] kinetics in 
exercise for the CK-deficient mice; i.e. [ADP] increased more rapidly than in the controls, 
suggesting therefore that QO  ^ would also increase more rapidly. This proposed 
dissociation of QO  ^ kinetics from [PCr] kinetics runs counter to observations in animals 
(Mahler et al., 1985) and humans (Rossiter et al., 1999, 2002) for submaximal sustained 
exercise. It should be pointed out that there has yet been no formal report of the degree to 
which [ADP] kinetics associate with those of for sustained exercise. It will be of 
considerable interest, therefore, to explore these issues in the CK-deficient mouse.
The implications of the model predictions of Roman et al. (2002) in the context of the 
present investigation would appear to be clear, however. The CK-deficient condition can 
be viewed as the extreme of a spectrum of CK activity. Thus, the prediction of fast QO2  
and therefore, presumably VO2  kinetics early in exercise with CK deficiency coheres with 
our demonstration of a progressive slowing of the phase II VO2  kinetics with increasing CK 
activity. We might, therefore predict that the slower phase II kinetics are accompanied by 
slower [ADP] kinetics but not necessarily slow [PCr] kinetics. This exciting prediction 
awaits investigation.
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As Pringle et al. (2002) have shown that the xn is related to muscle fibre type, it would be 
interesting to examine the relationship between CK activity and fibre type profiles in the 
context of the phase II VO2  kinetics. It has been shown that the highest CK concentrations 
are found in muscles with a high glycolytic potential (Newsholme et ah, 1978) and that, 
with the conversion of type II to type I fibres with training, there is an associated significant 
decrease in total CK activity (Apple and Rogers, 1 9 8 6 ) .  However, Zoll et al. (2002) found 
no significant difference between total CK activity and training status, despite significantly 
higher type I profiles in trained subjects. With the present results, it may be hypothesised 
that increased CK activity would be associated with an increased incidence of type II fibres; 
however, this awaits further investigation.
Previous studies have shown a positive correlation between both xn and VO2  peak and xn and 
0L (Hagberg et ah, 1 9 8 0 ;  Chilibeck et ah, 1 9 9 6 ) .  However, more recently it has been 
demonstrated by Whipp et ah ( 2 0 0 1 )  that considerable variation exists in these inter­
relationships: “if X VO2 is a stamen of stamina, it appears to be frail one”. The results of 
the present study are consistent with this suggestion, as no relationship was found between 
xii and VO2  peak or 0l. In addition, CK activity was not associated with VO2  peak or 0l 
(section 3 . 2 . 4 ,  Figure 3 . 3 6 , 3 . 3 3 ) .  The lack of coixelation with VO2 peak and 0 l strongly 
suggests that the relationship between xn and CK activity is not simply due to associated 
differences in aerobic fitness levels, but rather provides more weight for a “cause and 
effect” relationship.
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Uncoupling proteins
Although the mechanisms of action of UCP-2 and UCP-3 are unknown, the suggested 
function is similar to that found for UCP-1, namely acting as a leakage route in the inner 
mitochondrial membrane for protons to pass through without translating into an increased 
ATP production. Therefore, there would be an increased O2 utilisation without ATP 
production. Therefore, as a slower t  reflects less instantaneous O2 utilisation for the ATP 
requirement, it would be expected that UCP would not have any association with the phase 
II T. This was confirmed in the present study as indeed no relationship was found between 
UCP mRNA expression and xn for moderate-intensity exercise (section 3.3.2, Figure 3.38). 
It is possible that there may be a trend for lower UCP-2 levels with faster xn values. 
However, as only five subjects were analysed the confidence in this trend is minimal and 
requires further investigation to confirm the existence of any relationship.
4.2.1.2 Amplitude and gain parameters
In the present study it was found that the phase II on-transient gain (Gn on i.G. A VO2  /AWR)
averaged 11.0+0.5 ml.min"\W'^ and was similar for the o ff  transient, which is consistent 
with other literature (Linnarsson, 1974; Whipp et ah, 1982; Griffiths et ah, 1986; Paterson 
and Whipp, 1991; Ozyener et ah, 2001). In the present study, the range among individuals 
for Giion was relatively minor i.e. from 10.6 to 11.6 m hm in"\w \ It has been suggested by 
Mallory et ah (2002) that a greater gain during moderate-intensity exercise was associated
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with a higher Fo^ max- This relationship was not observed here and therefore differences 
between studies may indicate that individual variability exists (i.e. different subject pools 
measured) for the relationship between Fo^ peak and Gn.
Creatine kinase
It has been suggested by Wallimann et al. (1992) that the efficiency of ATP hydrolysis is 
increased when ATP resynthesis from PCr is catalysed by CK-MM, as it maintains a high 
ATP/ADP near the actomyosin ATPase and therefore, as demonstrated in equation 4.1, the 
AG available is increased as:
AG-AGi-RT*ln[ATP]/{[ADP].[Pi]} [4.1]
where AG is the free energy available from ATP hydrolysis, AGi is the initial free energy 
available, R and T are constants, and ln[ATP]/ {[ADP]. [Pi]} represents the inverse 
logarithmic function of [ATP]/[ADP]. [P|].
Therefore, it could be hypothesised that decreased CK activity would result in a lower 
[ATP]/[ADP] ratio, which (based on equation 4.1) would mean that a decreased AG is 
available. This would result in a slightly higher ATP requirement to perform a given work 
rate and, thereby an increased 0% cost. It might therefore be expected that a greater gain 
(A FO2 /AWR) might be expected to occur in association with a lower CK-MM activity.
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Studies have shown a positive effect of increased [Cr] or decreased [PCr] on mitochondrial 
respiration (e.g. Walsh et al, 2001a; Walsh et ah, 2001b). This may indicate that CK 
activity is not limiting in the exercise steady state, as the rate of mitochondrial respiration 
can be increased when the CK activity rate is caused to be increased. However, it is 
noteworthy that the effect of increased [Cr] on mitochondrial respiration has been shown to 
be greater in trained individuals (Tonkonogi & Sahlin, 1997 in isolated mitochondria; Zoll 
et ah, 2002 and Walsh et ah, 2001a; in skinned human skeletal muscle fibres). 
Furthermore, Walsh et ah (2001b) reported that in trained muscle fibres the positive effect 
of decreased [PCr] on mitochondrial respiration was greater. As the substrate 
concentrations (Cr and PCr) could influence the rate of respiration to a greater degree in 
trained muscle fibres, it might mean that the potential CK activity was greater than that for 
sedentary individuals. Nevertheless, Roman et ah (2002) reported that the PCr depletion 
after 60s was similar between CK-MM deficient and control mice. These authors therefore 
suggested that, in the steady state, cytoplasmic CK activity does not influence 
mitochondrial respiration. The results from the present study are in agreement with the 
suggestion of Roman et ah (2002), as no coixelation was evident between the moderate- 
intensity phase II gain (Gn) and CK activity (section 3.2.2, Figure 3.24).
Uncoupling proteins
As the suggested role of UCP is as an ‘inefficiency’ in ATP production per 0% molecule 
taken up, it may have been expected that a relationship between UCP expression and the
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phase II gain in moderate-intensity exercise (Gn) would exist. However, in the present 
study no relationship was found between UCP-3 and UCP-2 mRNA expression and Gn 
(section 3.3.2, Figure 3.39).
UCP should not be regarded only as a deleterious mechanism. For example, it has been 
suggested that a leakage of H'*' through UCP at rest may facilitate the many-fold increases 
in ATP production required during subsequent exercise (Boss et ah, 2000). At rest, high H^ 
flux rates may be maintained without ATP production, by a substantial portion of the H^ 
leaking through UCP rather than ATPase. Once the ATP demand is increased, the H^ ions 
are then diverted to the ATPase so that sufficient ATP is produced. Therefore, the 
expression of UCP may not result in inefficient H^ flux when it is not required (i.e. a higher 
VO2  gain), but rather may allow a precise and rapid switching between H^ leak and ATP 
synthesis in response to changes in ATP requirement. The present results found no 
relationship between the Gn and UCP, an observation which is consistent with this 
suggestion.
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4.3 VERY HEAVY-INTENSITY EXERCISE
4.3.1 ÊO2 peak correction
An interesting and important result in the present study that must be addressed prior to 
discussion of the Vo^  response is that the end-exercise for the 1 2  minute fatiguing test 
was slightly but significantly lower than that for the 6  minute fatiguing test. This finding is 
not, at first sight, consistent with the literature, which suggests that the FO^  response to all 
fatiguing WRs above the CP will reach peak (e.g. Whipp and Mahler, 1980; Poole et al., 
1988; Whipp and Ozyener, 1998; Ozyener et ah, 2001).
Comprehensive individual data are not available in the studies that have examined the Fo^  
response to different WRs above the CP (Whipp and Mahler, 1980; Poole et ah, 1988; 
Pringle and Jones, 2002; Miura et ah, 2002; Coates et ah, 2003). However, a single 
individual’s Fo^ response profiles to multiple, square-wave exercise tests of different WRs 
are shown in Whipp and Mahler (1980). Close visual examination of each Fo^ shows that, 
as the tolerable exercise time decreased (and therefore FOj peak should have been attained), 
the actual end exercise Fo^ achieved was marginally lower for those WRs which resulted 
in a tolerance time of ~10 min and ~7 min (-3.7 l.min'^ and -3.6 hm in'\ respectively), 
compared with the WR that lasted ~4 min (-3.8 hmin'^) (shown in appendix iii). In 
addition, Poole et al. (1988) suggested that, for tests performed slightly above CP (i.e.
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closer to the “ 1 2  minute” test versus the “ 6  minute” test of the present study), individual 
variability in teims of achieving a similar end-exercise VO2  occuiTed. Thus, it was stated 
that in three subjects end-exercise VO2  slightly exceeded VO2  peak, whereas in the remaining 
five, it was either equal or slightly lower than VO2  peak. In light of the data from these 
studies, the lower Fo^peak in the “ 1 2  minute” versus the “ 6  minute” constant work rates 
may represent a true physiological outcome. Further investigation is warranted to resolve 
this issue.
In the present study, all experiments were conducted under rigorously controlled 
conditions; i.e. a controlled laboratory environment, consistency of the subject’s physical 
condition, randomisation of trials, a consistent amount of verbal encouragement, retrials to 
attempt to obtain a similar end-exercise Fo^, and evident subject exhaustion on each test. 
In addition, the end-exercise HR was the same for the “ 6  minute” and “ 12 minute” tests, 
which strongly suggests that a maximum effort had been given; although it is noted that HR 
peak is not always a reliable indicator of having reached VO2  peak as it has been shown (at 
least in highly-trained endurance athletes) stroke volume may continue to increase at 
maximum exercise (Gledhill et al., 1994). Thus, using HR peak as an indicator of reaching 
VO2  peak must be approached with caution.
However, until further investigation with more subjects reveals whether or not the lower 
end-exercise VO2  found in the “ 1 2  minute” test versus the “ 6  minute” test is consistent, for
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the purposes of discussion the VO2  response for the “ 1 2  minute” test was expressed as a 
corrected value; that is, to quantify the VO2  amplitude, the “ 1 2  minute” end-exercise VO2  
( VO2  ee) was extrapolated to the VO2  ee value for the “ 6  minute” test. It is of note that this 
correction does not change any trends reported in the present study, but only reflects the Idifferences to a greater degree.
Previous studies have investigated the temporal features of the VO2  response to exercise 
above the lactate threshold ( 0 l) .  However, as discussed in section 1 . 4 . 3 ,  it is clear that 
exercise above critical power (CP) results in a VO2  kinetic response, which is qualitatively
5quite different from that for WRs lying just above 0l (Ozyener et ah, 2001). That is, above
CP VO2  continues to increase throughout the test to attain Fo^peak and, therefore, to the 
limit of tolerance. Although Ozyener et al. (2001) have examined the VO2  response to 
exercise which was clearly above CP (as peak was reached), the exercise intensity was 
prescribed as 80% ( Fo^ peak-Or). In addition, Pringle et al. (2003) examined Fo^ kinetics at 
70% ( VO2  peak-Or), which may have been above CP but this cannot be confirmed as the 
duration of exercise was not continued to the limit of tolerance. As CP occurs at variable 
percentages of (Fo^peak-Or) (Poole et ah, 1988), prescribing exercise intensity based on
( VO2  peak“0L) does not necessarily ensure that WRs of similar metabolic intensity are being 
performed between individuals. The present study is the first (to the author’s knowledge), 
which has formally explored VO2  kinetics in the supra-CP range; i.e. by utilising each
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subject’s power-duration curve to estimate the CP. Furthermore, also for the first time, 
more than one work rate was investigated in this intensity domain i.e. two WR’s were used 
and importantly, were standardised across the subjects in terms of predicted exercise 
durations (from the P-t relationship) of 6  and 12 minutes.
In addition, in the study of Pringle et al. (2003), a triple exponential model was used to fit 
each of the phases (i.e. phase I, phase II, and the slow component), while in the study 
of Ozyener et al. (2001) a double exponential model (omitting the phase I response) was 
used. However, as suggested by Rossiter et al. (2000), conferring a discriminable model 
structure on the Fo^ slow component cannot be justified, given the short duration and 
small amplitude of response which compromises confidence in the associated fit. 
Therefore, in the present study, only the phase II response was fit (as a simple exponential), 
and identification of the onset of the slow component was discerned utilising the strategy 
described by Rossiter et al. (2000) (see section 2.4.3). In addition, individual parameter 
values have been reported rather than simply mean values (e.g. Ozyener et ah, 2001; 
Pringle et ah, 2002) in order to investigate the individual variation in the supra-CP VO2  
kinetics; i.e. examining the proportional contributions to the end-exercise VO2  of phase II 
and the slow component.
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4.3.2.1 Temporal parameters
Creatine kinase
' 1
:
+ 14.3.2 Phase II
It was found in the present study the supra-CP phase II time constant (t) value varied
between individuals from 15 to 46 s and that this variability was not associated with any of f
.the other VO2  response parameters or with VO2  peak or A[La].
■iIn the present study, consistent with the results discussed earlier for moderate-intensity, Ithere was trend for lower CK activity to be associated with faster Xn values although this 
did not reach significance (section 3.2.3, Figure 3.25, 3.26). This suggests that CK activity 
may also be involved in the control of VO2  at the onset of supra-CP exercise (i.e. it is still 
manifest during heavy-intensity exercise), although this does not preclude involvement of 
other factors whose significance may vary across subjects. This suggestion might explain
■
the discrepant results of Rossiter et al. who reported that during heavy-intensity exercise the |  ,
rate of PCr breakdown is both associated (Rossiter et ah, 2002) and dissociated (Rossiter,
2001) with xii Vo2 . The reasons for the difference between these two studies is unclear but
would be consistent with the suggestion that some other factor may limit VO2  during 
heavy-intensity exercise in some subjects (but not others) and, hence, the difference 
between studies may be related to characteristics of the subject pool.
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Fibre-type distribution is known to vary widely across subjects. It is of interest, therefore, 
that Pringle et al, (2002) have reported that, in the very heavy-intensity domain no 
relationship existed between the xn and the incidence of type IIx fibres. One may 
speculate, therefore, that subjects having increased proportions of type IIx fibres may have 
differential QO  ^ (and therefore VO2 ) control systems acting, compared with subjects with 
lower type IIx fibre profiles. This is interesting proposal requires further investigation.
Uncoupling proteins
As described for moderate-intensity exercise, if the proposed mechanism of UCP is an 
increased O2 without ATP production rather than an inefficiency in the ŸO2  response, no 
association between UCP’s and Xn would be expected. We can confirm that, in the present 
study there was no correlation between UCP expression and the Xn for supra-CP exercise 
(section 3.3.3, Figure 3.40, 3.41).
4.3.2.2 Amplitude and gain parameters
The proportion of the VO2  increase that phase II contributed to the overall VO2  response for 
supra-critical power (i.e An expressed as a % of Aee) varied by up to 9% between 
individuals, and the phase II gain (Gn) ranged from 9.0 to 10.2 m l.m in"\w \
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It was shown by Pringle et al. (2002) that subjects with a high type II fibre content had a 
low Gii, longer th and a greater proportional contribution from the slow component to the 
end-exercise VO2  value. Barstow et al. (1996) reported a similar relationship between type 
II fibres incidence and G n , but not xn. In the present study no relationship was found 
between the supra-CP xn and corresponding G n. Therefore, it would be interesting to 
observe which Vo2  kinetic parameter (if any) might correlate with a subject’s fibre type 
profile.
Creatine kinase
It was of surprise that the Gn for very heavy-intensity exercise was correlated with CK 
activity, with lower CK activity being associated with a smaller Gn .(section 3.2.3). This 
relationship was significant for “12 minute” (Figure 3.29) and there was a similar trend for 
“ 6  minute” (Figure 3.30). Barstow et al. (1996) and Pringle et al. (2002) have shown that a 
high incidence of type II fibres was associated with a lower Gn for heavy-intensity exercise. 
Based on their results, it may be expected that lower CK activity would be associated with 
an increased type II fibre profile. However, as type II fibres have also been associated with 
slower Xii (Pringle et al., 2002) and, in the present study, increased CK activity was 
associated with a slower Xn, the relationship with CK activity probably is not only simply 
one involving fibre-type profile.
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Uncoupling proteins
As the very heavy-intensity domain was associated with a decreased O2 cost, there would 
be no a priori expectation that U C P  levels would be related to the phase II gain (G n ); and 
indeed, in the present study, no significant relationship was found between U C P  expression 
and Gii (section 3.3.3, Figure 3.44, 3.45). However, there was a statistically insignificant 
trend for a lower G n  with lower U C P -2  expression, which requires further investigation 
with a much larger subject group (i.e. only five subjects were available for U C P -2  
analysis).
4.3.3 Slow component
4.3.3.1 Temporal parameters
In the present study the rate of slow component increase (Age 5-3) ranged widely, from 0.22 
to as much as 0.64 l.min'L
Creatine kinase
The rate of the slow component increase was not significantly related to CK activity 
(section 3.2.3, Figure 3.27, 3.28). However, it should be pointed out that a nonsignificant 
trend was evident for the “6 minute” test, with a low rate of slow component increase
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tending to occur with an increased level of CK activity (Figure 3.28). This issue should 
receive further investigation with an increased subject pool.
Uncoupling proteins
In the present study, we have shown that there was no relationship between UCP 
expression and the rate of the slow component increase (Ascs-s) (section 3.3.3, Figure 3.42, 
3.43). It has been suggested that UCP-2 and UCP-3 may act at the inner mitochondrial 
membrane to channel the leak of from the inner membrane spaces to the matrix rather 
than through ATPase reactions, therefore resulting in inefficient ATP production. The 
slow component seen at work rates above 0 l  is an inefficiency with respect to O2 cost, 
compared to moderate-intensity work rates (Paterson and Whipp, 1991). In the present 
study there was the suggestion of a trend for UCP-2 to be related to the early rate of the 
VO2 slow component increase; i.e. with increased UCP-2 expression being associated with 
a slower (rather than faster) rate of slow component increase. Because of the small number 
of subjects (n=5), these data should be interpreted with caution.
4.3.3.2 Amplitude and gain parameters
In the present study there was a range in the size of the slow component, expressed at end- 
exercise, with the slow component amplitude (Age) ranging from 0.47 to 1.05 l.min"\ Age 
expressed as a proportion of the total in increase in VO2  (Asc as a % of Aee) ranged from
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17 to 34%, and the slow component gain (Ggc) ranged from 2.1 to 3.8 ml.min"\W'\ It was 
also of interest that the start of the slow component occurred later during the “ 1 2  minute” 
test (154±10s) versus the “ 6  minute” test (127+18s) in all subjects. When the calculation of 
[(four X t)  + time for phase I) is performed to approximate when the phase II steady state 
should occur, it is estimated that phase II for the “ 6  minute” test should have ended at 
-137s which is just after the time point at which the slow component was discerned (i.e. 
127 s). However, for the “12 minute” test the phase II steady state should occur at 125s, 
which is earlier than the discerned start of the slow component (i.e. 154 s). This suggests 
that in the “ 1 2  minute” test the slow component is of delayed onset occurring just after 
phase II steady state is reached, whereas in the “ 6  minute” test the slow component occurs 
at, if not simultaneous with the end of the phase II response.
A similar trend for the VO2  slow component to emerge later at a higher WR was found by 
Ozyener et al. (2001) in which the time delay for the slow component was 154+55s in 
heavy exercise but only 137±28s in very heavy exercise. The reasons for the earlier 
emergence of the slow component at a higher work rate is unknown, but it may provide 
additional information to help resolve the mechanisms of the slow component, as factors 
hypothesised to affect the slow component can be studied within an individual rather than 
across individuals, to see if the factors hypothesised are also manifest earlier at higher work 
rates.
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Creatine kinase
No significant relationship was found between the end-exercise magnitude of the VO2  slow 
component and CK activity. However, there was a trend for increased CK activity with a 
smaller slow component amplitude (section 3.2.3, Figure 3.28). The results of the present 
study have also shown a relationship of increased CK activity with slower th values 
(section 3.2.2, Figure 3.23; section 3.2.3, Figure 3.25 and 3.26), and others have shown an 
association between slower th values with increased type II fibre profiles (Pringle et al.,
2002). Therefore, if CK activity is associated with fibre type and if the VO2  slow 
component is related to type II fibre recruitment as some studies have suggested (Shinohara 
and Moritani, 1992; Barstow et ah, 1996; Burnley et al., 2002; Pringle et al, 2002), it might 
have been expected that if there was a relationship between CK activity and the slow 
component it would be increased CK activity with a greater slow component amplitude. 
However, this was not the case in the present study. Therefore, further investigation with 
an increased subject pool is required to confirm whether a relationship is evident between 
the amplitude of the VO2  slow component and CK activity, and further to determine 
whether there is a relationship with fibre type.
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Uncoupling proteins
In the present study no relationship was found between UCP expression and either the slow 
component amplitude or gain (Age, Ggc) (section 3.3.3, Figure 3.46, 3.47). It was evident 
that a trend may have existed for increased UCP-2 to occur with a smaller slow component. 
However, this trend is not consistent with the suggested mechanism of UCP (which would 
suggest increased UCP-2 expression occurring with an increased slow component 
amplitude) The extent to which this represents the small subject number (n=5) requires 
further investigation.
In this context, the study of Russell et al. (2002), which reported a relationship between 
UCP-3 (but not UCP-2) and the VO2  slow component is demanding of some discussion. 
There are several major shortcomings in experimental design and data analysis. It is 
possible that the relationship was an artefact of the effect of the subjects working at 
different relative exercise intensities.
Firstly, as evident from the present experiments in the very heavy domain, it is critical in 
establishing the amplitude of the slow component that the work rate for each individual be 
established relative to his/her own markers of exercise intensity domain. Russell et al. 
(2 0 0 2 ) established the work rates for each subject relative only to the lactate threshold (0 l).
However, the accuracy of the 0l determination should be considered. The identification of 
0L was based on directly measured blood [La] profiles. However, the sample site (the
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.antecubital vein) was entirely inappropriate. Because of substantial and variable lactate
'Iclearance by the relatively “non-exercising” forearm muscles (Brooks et al., 2000),
These several factors, perhaps not surprisingly, conspire to generate clearly different 
exercise intensities in the two subject groups. Thus, Russell et al. (2002) state that their 
recreationally active subjects were exhausted or reached VO2  max, whereas in the trained 
subjects FO2 was able to stabilise - suggesting that the work rates were lower than CP. As 
the VO2  slow component amplitude and its ability to attain a steady-state varies with 
exercise intensity, it is imperative that identical intensities are used to be able to interpret 
meaningfully the relative differences in the slow component amplitude with UCP data. As
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especially when the venous blood is not “arterialised” the primary lactate accumulation |
profile will necessarily be contaminated and thus lead to underestimation of 0l (Yoshida,
1986). Further, the degree of forearm lactate clearance may vary with fitness levels.
' *affecting the estimated threshold in the two groups differently.
"I
In addition, because Russell et al. (2002) used a slow ramp test of step increases every 
fourth minute and sampled blood only every four minutes, the resulting data density will be 
poor. Thus, there would be minimal data in the moderate region with which to establish the
■1:;baseline, against which judgements of the subsequent onset of blood [lactate] increase 
would be made. Also [La] typically does not generate a precise breakpoint, in the way that 
the widely-used gas exchange markers do (Jones, 1982; Beaver et al., 1985; Whipp et al.,
1986).
the trained subjects were at a lower relative exercise intensity it would be expected that - 
had they performed a relative intensity equivalent to that of the recreational group - the 
slow component would have been larger than actually reported. This assertion agrees with 
the statement by Russell et al. (2002) that their trained subjects showed a smaller slow 
component.
Further, criticism of the study of Russell et al. (2002) is that the amplitude of the slow 
component was calculated as an arbitrary increase in VOj from 3 to 6  minutes (e.g. Roston 
et ah, 1987), rather than discerning the onset of the slow component from modeling 
analyses (see section 1.4.2). Again, this approach may also result in differences in the slow 
component amplitude among individuals, as the slow component may emerge in the range 
of 90 to 160 s (Whipp et ah, 1987; Paterson and Whipp, 1991; Barstow and Mole, 1991; 
Barstow et ah, 1994; Scheuermann et ah, 1998; Bell et ah, 2001; Ozyener et ah, 2001). 
Therefore, taking these several criticisms together, the report of Russell et al. (2002) of a 
smaller association with a slow component with lower UCP-3 expression has to be
viewed with considerable skepticism.
Rossiter et ah (2002) have shown that slow component was also evident in the PCr 
breakdown for exercise on-transients supra 0l. This was taken to indicate that there is an 
increased phosphate cost of force production rather than an increased O2 cost for phosphate 
production. The results of the present study, showing no correlation between UCP and the 
FO2  slow component amplitude, are consistent with this suggestion. That is, the suggested
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mechanism of UCP as a proton leak would only result in an increased O2 uptake for the 
ATP produced, rather than an increased phosphate cost for force production.
Many investigators at present favour an involvement of recruitment of less efficient type II 
fibres in the mechanism of the VO2  slow component (Shinohara and Moritani, 1992; 
Barstow et al., 1996; Burnley et al., 2002). The extent to which UCPs are selectively 
expressed in different fibre types in humans is equivocal however. Russell et al. (2002) 
demonstrated a positive correlation between the proportion of type Ila fibres and UCP-3 in 
their recreationally active but not their trained subjects, whereas Calsbeek et al. (2002) 
showed a significant positive correlation between type I fibre content and UCP-3. In 
contrast, the relationship between UCP-2 and fibre type profile was not reported in the 
study of Russell et al. (2002); neither was UCP-2 measured in the study of Calsbeek et al. 
(2002). Therefore, the relationship between UCP levels and fibre type remains to be clearly 
established. Without this link between vital information, any putative recruitment of type II 
fibres and the VO2  slow component through a mechanism related to greater UCPs 
expression must remain only speculative.
The literature to date is also equivocal regarding the relationship between UCP expression 
and aerobic fitness levels in humans. Both UCP-2 and UCP-3 have been reported to be 
lower in subjects with a higher Fo^peak (Russell et al., 2002) and after training (Schrauwen 
et al, 2001; Tonkonogi et al, 2000). However, Calsbeek et al. (2002) showed no correlation 
between UCP-3 and peak in a study of 24 human subjects. The results from the present
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study are in agreement with those of Calsbeek et al. (2002), as no relationship was found 
between UCP expression and indicators of aerobic fitness (O l , CP and peak) (section 
3.3.4, Figures 3.48, 3.49, 3.51). However, it is interesting to note that a relationship was 
evident between the anaerobic capacity parameter of the P-t relationship (W’) and UCP-2 
(section 3.3.4, Figure 3.50). While this is suggestive of a predisposition towards anaerobic 
metabolism (perhaps because of cellular inefficiencies in O2 utilisation), resolution of this 
issue is beyond the scope of present investigation.
In the present study, it must be acknowledged that the interpretation of UCP measured from 
mRNA expression is not without problems. UCP mRNA expression was measured, rather 
than UCP protein expression, and it should be recognised that mRNA expression does not 
necessarily correlate with protein levels as the regulation of protein translation can be 
complex. A valid technique for UCP protein analysis from human muscle biopsy material 
is not currently available; this reflects the small muscle volume taken. Therefore, mRNA 
expression is the best indicator until further methodological advancements are made. Thus, 
it cannot be categorically stated that the UCP-3 is not a mechanism involved in 
development of the VO2  slow component and its differential prominence among different 
individuals differentiating the magnitude of the slow component among individuals. The 
data from the present study do suggest that this explanation of the slow component, as 
proposed by Russell et al. (2002), is questionable.
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4.4 COMPARISON OF Vo, KINETICS FOR MODERATE- AND VERY HEAVY-
4.4.1 Temporal parameters
INTENSITY EXERCISE
The present study found that the Xn value was significantly faster during moderate 
exercise (21±4s) than that of the “ 6  minute” very heavy-intensity exercise (29±9s) (section, I
3.2.2.2, Figure 3.9) and, although not significant, a trend to be faster than “12 minute” very 
heavy-intensity exercise (27±10s) (section 3.1.2.1, Figure 3.6).
The results from other studies to date have shown that, in comparison to moderate intensity 
exercise Xn above 9l was significantly longer (Jones et ah, 2002; Koga et ah, 1999;
Paterson and Whipp, 1991; Jones et ah, 2002), showed a trend to be longer (Barstow and 
Mole, 1991; Paterson et ah, 2003), or showed no significant difference (Ozyener et ah,
2001; Carter et ah, 2000; Pringle et ah, 2003). However, the exercise intensities utilised in . 
each of the studies are likely to have varied to an unknown extent, as the WRs were 
assigned as a percentage of the difference between VO2  peak and 0 l . Therefore, whether the 
work rates elicited were heavy-intensity or very heavy-intensity exercise cannot be 
determined with high confidence. The present results suggest that the severity of the 
intensity of exercise may be important to the degree of difference observed between the xn 
values. In addition, the above studies used different modelling techniques to identify the 
appropriate phase II component (some fitting the slow component response; some not).
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which may have also contributed to the conflicting results. Whether the phase II VO2  
response conforms to a dynamically-linear system above 0 l  and above CP has important 
implications regarding the possible control mechanisms of VO2 . If % n values are 
independent of work rate, then it suggests that the system is a first order system, limited by 
a single control mechanism.
However, recent studies by and Brittain et al. (2001) and Paterson et al. (2003) have 
reported that th is faster for an equal change in work rate into the lower region versus the 
upper region of moderate-intensity exercise (Brittain et al., 2001; Paterson et al., 2003) and 
further slower into the lower region of heavy-intensity exercise (Paterson et al., 2003). In 
addition, a single work rate step to the lower region of heavy-intensity exercise resulted in a 
phase II VO2  response that was not significantly slower than for a single step into the upper 
region of moderate-intensity exercise (there was, however, a trend for Tn to be longer); 
however, xn was significantly slower than for a single step into the lower region of 
moderate-intensity exercise. These results suggest the phase II VO2  response does not 
conform to a dynamically linear system.
The mechanism responsible for the slower Xn is unknown. However, as the present study 
demonstrated a trend for CK activity to be negatively associated with xu in the very heavy- 
intensity domain, it might be expected that a mechanism affecting CK activity could be 
involved in controlling the phase II VO2  response profile.
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It has been suggested that intramuscular pH and Pi may dissociate CK-mi from the inner 
mitochondrial membrane, which may decrease the rate of mitochondrial respiration (Walsh 
et al., 2002). As a substantial accumulation of H^ and Pi can occur during very heavy- 
intensity exercise it could be hypothesised that the acute effect of inhibiting CK-mi activity 
is a slowing of tn during very heavy-intensity exercise compared with that of moderate 
exercise in which there is a relative lack of increase of H^ and Pi. In the present study, the 
phase II moderate-intensity VO2  response was faster than that of the very heavy 6  minutes 
exercise test (as discussed above). However, whether this was due to an acute decrease in 
CK-mi activity at the higher work rates cannot be determined in the present study, as 
biopsy samples would need to have been taken during exercise. In addition, the ability to 
accurately quantify CK-mi from human tissue samples is still debatable due to the very low 
proportion CK-mi compared to CK-MM) (Wallimann, 1992). The finding that the phase II 
Vo2  X was slower in the “ 6  minute” than versus the “ 1 2  minute” test would be consistent 
with the effect of pH and/or Pi, as once above CP, H^ and Pi continually accumulate which 
would be hypothesised to have an increasingly potent effect on xn.
It has also been suggested that the slower VO2  kinetics during heavy-intensity exercise may 
be because O2 delivery becomes limiting (Gerbino et al., 1996; Hughson et al., 1996; 
MacDonald et al., 1997; Bohnert et al., 1998; Grasssi et al., 2001). However, the evidence 
from Rossiter et al. (2002) that the kinetics of [PCr] breakdown and VO2  are so similar
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during heavy-intensity exercise suggests that this may not be the case, but rather an 
intramuscular limit may exist such as inhibition of CK-mi.
As it has been argued that the slower xn values are associated witfi increased type II fibre 
content (Pringle et al., 2003), individual differences in fibre type profiles might well 
contribute to the degree of phase II slowing which occurs at the higher WRs; i.e. 
individuals who have more type II fibres may therefore show a greater degree of slowing 
from moderate to > 0 l  exercise as proportionally more type II fibres would be recruited 
above 0 l and, as importantly, above CP. This trend can, in fact, be seen in the study of 
Pringle et al. (2003), in which there appears to have been a trend for subject groups with the 
highest amount of type II fibres to show the greatest slowing at the higher work rates (i.e. 
an 8 s difference, compared with 3 s for those with a low percentage of type II fibres). 
Previous studies in which individual data were available showed similar inter-subject 
variability in the degree of xn slowing (Ozyener et al., 2001; Paterson and Whipp, 1991; 
Bar stow and Mole, 1991). Therefore, it is possible this effect of inter-subject variability of 
the Xn above CP may be dependent on fibre type, which could perhaps explain the 
differences seen in some studies but not others.
In the present study, one subject (subject 6 ) showed a significantly slower x n value for the 
very heavy intensity exercise (average 46s) compared with moderate (25s); others however, 
showed a minimal difference (i.e. subject 5: very heavy average—16s, moderate=16s). It 
would be interesting, therefore, to see if a relationship exists, on an individual basis.
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between the amount of slowing that occurs from moderate- to heavy- intensity exercise and 
the proportion of type II fibres.
4,4.2 Amplitude and gain parameters
The present study found that the phase II gain (G n ) for moderate-intensity exercise 
( 1 1 .0 + 0 .4  ml.min"^W*) was significantly higher than that for very heavy-intensity exercise 
(average 9 .7 ± 0 .4  ml.min"\W'^) (section 3 .1 .2 .1 ,  3 .7 ;  section 3 .2 .2 .2 ,  Figure 3 .1 0 ) .  These 
results differed from those of Paterson and Whipp ( 1 9 9 1 )  and of Barstow and Mole (1 9 9 1 ) .  
They are, however, in accord with those of Jones et al. ( 2 0 0 2 )  and Pringle et al. (2 0 0 3 ) :  in 
both of these studies a significantly smaller G  n was found for exercise above Ol (9 .9  and
9 .1  ml.min"\W'\ for the studies, respectively) than below ( 1 0 .8  and 1 0 .6  ml.min'\W'% 
respectively). Although Ozyener et al. (2 0 0 1 )  did not report a significant difference, the 
moderate-intensity G n  was ll.Sml.min’^W'* compared with 1 0 .7  ml.min'\W'^ for very 
heavy-intensity exercise. Similarly, Carter et al. (2 0 0 2 )  showed a trend for a decreased G n  
with increased running speed. As previously mentioned it has been shown that subjects 
with a high proportion of type II fibres evidence a lower gain (Pringle et al., 2 0 0 3 ;  Barstow 
et al., 1 9 9 6 ) .  The finding in the present study that the phase II gain was lower in very 
heavy-intensity compared with moderate-intensity exercise is compatible with this 
suggestion as it would be expected that more type II fibres are recruited at higher intensities 
(Essen, 1 9 7 7 ; Jones and Round, 1 9 9 0 ) .  The mechanisms causing a greater oxidative 
efficiency in type II fibres remain unknown (Heglund & Cavagna, 1 9 8 7 ;  Pringle et al.,
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2003). Regardless, a lower phase II gain for very heavy-intensity exercise provides further 
evidence that the Vo^  response above Ol and particularly above CP does not conform to a 
dynamically linear system. This suggests that multiple factors, dependent on exercise 
intensity, are involved in the control of VO2  and therefore muscle O2 consumption.
4.5 CONCLUSIONS
With regard to objective 1, the present study has shown for the first time that the phase II 
VO2  time constant (xn) is related, inversely, to CK activity in the vastus lateralis. Although
the mechanism(s) through which this interaction occurs could not be elucidated, the results 
concur with recent literature (Roman et al., 2002) which suggests decreased CK activity 
would be associated with faster VO2 . A limitation of the present study is that the small 
biopsy samples taken may not be representative of the entire muscle group and that samples 
were taken only from one of the muscle groups involved in cycling. Therefore, we cannot 
preclude the possibility that these factors could potentially lead to outliers in the results. 
Further investigation with an increased sample size is required to firmly elucidate the 
consistency and nature of the relationship between CK activity and x». In addition, it was 
of interest that the phase II gain (G n ) for the supra-CP test was positively related to the CK 
activity. In light of recent suggestions of a significant role for fibre type on VO2  kinetics (xn 
and G n ), it would be interesting to investigate the relationship between (a) CK activity and 
fibre type, and (b) CK activity and xn following training-induced changes in fibre-type 
profile.
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With regard to objective 2, the present study demonstrated that inter-subject variability 
exists in the VO2  kinetic parameters to very heavy-intensity exercise, when appropriate 
exercise intensity definition and modelling are prescribed. No relationship was found Ibetween the VO2  kinetic parameters and blood [La] or with fitness levels. In addition no 
significant relationship was found between either CK activity or UCP mRNA expression
and VO2  kinetics (except Gn for “12 minute”) above CP. Therefore, future studies are #
'
needed to investigate relationships underlying this kinetic variability. It will be particularly ft
' j
interesting to investigate the relationship between VO2  kinetics among individuals having a 
wide distribution of muscle fibre type profile.
In addition, the VO2  kinetics for moderate- and very heavy-intensity exercise were 
compared, as the literature remains equivocal on this point. It was shown that the phase II 
(tii) was slower above CP compared with moderate-intensity exercise and, also that the 
phase II gain was lower above CP. These observations clearly highlight the fact that VO2  
does not conform to a dynamically linear system, and argue that a spectrum of 
mechanism(s) controlling the VO2  (and therefore QO2  ) kinetics varies and also probably 
differs with intensity.
In this context, the design limitation of the present study should be noted, in which only 
two (or, on occasion one) repeat were undertaken, (whereas the moderate-intensity exercise
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used six repeats). Although the supra-CP VO2  responses had a large asymptotic (or 
predicted steady-state) and therefore provided parameter estimates with a sufficiently small 
SD, it would have been preferable to have been able to increase the number of repeats so as 
to optimise the signal-to-noise ratio. However, multiple repeats were not feasible in the 
present study due to temporal constraints as subjects had each been asked to perform —14 
tests prior to the 6  and 12 minute supra-CP tests. Future studies should therefore strive to 
ensure that the most appropriate number of repeats is performed for high resolution of the 
VO2  kinetic response. This is particularly important if functional significance of the 
individual differences in VO2  kinetic responses and their potential relationships with other 
variables (as highlighted in the present study) are to be resolved convincingly.
With regard to objective 3 it was shown that, unlike the conclusions of Russell et al. (2002), 
there was no relationship between UCP-3 mRNA expression and the slow component 
amplitude for supra-CP exercise. The present study did suggest that there may be a trend 
between UCP-2 mRNA expression and the slow component amplitude. However, as data 
from only five subjects were available, more comprehensive investigations will be required 
to firmly elucidate any such relationship between UCP-2 expression and the VOg slow 
component.
Another limitation of the present study is the recognition that interpretation of relationships 
involving UCP mRNA expression must be approached with caution, as mRNA expression 
does not necessarily reflect protein expression, owing to the complexities of translation
179
control. However, methodological constraints currently preclude analysis of UCP protein 
expression due to the small volume of muscle that can be obtained with a muscle biopsy 
sample. Therefore, mRNA expression is presently the best indicator available indicator of 
UCP levels until further methodological advancements are made.
The present study has examined the VO2  kinetics during moderate- and very heavy- 
intensity exercise and shown significant relationships with creatine kinase but not 
uncoupling protein. However, as some trends were evident between VO2  kinetics and CK 
and between VO2  kinetics UCP, more investigation with an increased subject pool needs to 
be performed to firmly elucidate the role of creatine kinase and it association with VO2  
kinetics and muscle fibre-type profiles and activation patterns.
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University of Glasgow 
Institute of Biomedical and Life Sciences 
University of Glasgow
INFORMATION SHEET
TITLE OF INVESTIGATION: Influence of creatine kinase and mitochondrial uncoupling proteins on the 
control of muscle oxygen consumption during exercise in healthy human subjects
You have been invited to take part in a research study looking at the influence of muscle proteins on exercise 
performance. In order to help you to understand what the investigation is about, please read the following 
information carefully. If there are any points that need further explanation, please ask a member of the research 
team. It is important that you understand what you are volunteering to do and are completely happy with all the 
information before you sign this form. : tB:'igWhat is the purpose of the study? It has been proposed that two muscle proteins (creatine kinase and 
mitochondrial uncoupling proteins) and one gene (the angiotensin-converting enzyme or ACE gene) may influence 
how quickly oxygen is consumed during exercise and may therefore dictate how well an individual may exercise 
before fatiguing. This study aims to investigate this possibility by asking fourteen healthy volunteers to exercise.
The results obtained could be important in both healtli (to aid sporting performance) and disease (where exercise 
can prove very difficult).
Why have I been chosen? You have been selected as a possible participant in this investigation because you are 
aerobically trained and in good health. Before you become a subject, you will complete a medical questionnaire.
People who have asthma, heart-related and/or circulatory problems, hypertension or any other contraindicated 
condition will not be allowed to take part in the study.
Do I have to take part? It is up to you to decide whether or not to take part. If you decide to take part, you will be 
given this information sheet to keep and you will be asked to sign a consent form. If you decide to take part, you are 
still free to withdraw at any time and without giving a reason.
What will happen to me if I take part? You will be asked to visit the laboratory on no more than nineteen 
separate days over a three-month period. This will provide us with up to four “repeat” responses for each of the 
exercise protocols described below. However, in our experience, two to three repeats are normally sufficient to 
provide clear response profiles. Each visit will last no more than 2 hours.
On your first visit, you will be introduced to the laboratory personnel and familiarised with all the equipment used.
You will be asked to complete two confidential questionnaires: the first will allow us to obtain information related 
to your general health; and the second will allow us to quantify your past exercise/activity involvement. You will 
then be asked to perform what is called a “progressive exercise test” on a cycle ergometer (exercise bike). During 
this test, the workload will start at a very low level and increase gradually every minute. The idea is that you keep 
going until you can do no more. The test will be stopped when you decide you can go no longer.
On your second visit, you will repeat the “progressive exercise test”. This will allow us to determine your fitness 
and therefore to select the exercise levels for the remaining tests. In addition, we will ask you to take a small sample 
of the cells that line the inside of your cheek, with a small disposable spatula. We will subsequently analyse these 
cells for ACE gene function.
On the third visit, while you are lying down, a small sample of tissue (approximately 100 milligrams, 2 mm long and 2 
mm diameter) will be taken from one of your thigh muscles, using a fine needle to be inserted into one of your thigh 
muscles. To minimise any discomfort, a local anaesthetic will be injected into the sample site prior to the sample being 
taken.
On each subsequent visits, the exercise testing set-up remams the same but the exercise protocol changes. Instead 
of the workload gradually rising constantly throughout the test, the workload will change instantaneously between 
one level and another - we call this “constant-load exercise”. You will exercise from a period o f very light exercise 
(almost no resistance in the pedals) to either “moderate” exercise (for no more than 10 minutes) or to “heavy” 
exercise (for no more than 20 minutes or until you camiot continue, whichever comes sooner). We would like you to 
complete a total four “moderate exercise tests, and no more than twelve “heavy” exercise tests (four at each of three 
different work rates)
 :
In all tests we will ask you to breath through a “snorkel” type mouthpiece with a noseclip in place. This is so we 
can monitor the air you breathe in and out.
We will be taking blood from you at various times during all tests. With the use of a surgical needle, a small plastic 
tube (called a catheter) will be inserted into a vein on the back of your hand. This is common practice and will 
cause only a mild “prick” of the skin. A small tap is coimected to the inserted tube, which allows repeated samples 
of blood to be taken without having to use a needle each time. No more than 60 ml (about 6 dessert spoons) of 
blood is taken in any one test.
During the test, a strapping (bandages and elastic tape) will be placed around your right thigh. This is used to keep 
in place two optodes flhese emit and detect light). You will not feel the light emitted from the optodes. It is used to 
estimate the amount of oxygen in your thigh muscles. The strapping will also be used to keep m place two surface 
electrodes, that will be used to monitor the electrical activity in your thigh muscle. Great care will be taken when 
putting on the strapping and you should feel no discomfort. A similar, but much smaller, device will be placed on 
your finger to measure the amount of oxygen in your blood. Each of these devices are harmless. In order to 
calibrate the optode device on your leg, you will asked to perform a maximal contraction of your thigh muscles 
(lasting 10-20 seconds).
On the handlebars of the cycle ergometer is a small knob that controls an illuminated scale extending from 0% to 
100%. By turning the knob, you can progressively illuminate the scale until you reach the desired point on the scale.
At various points in the test, you will be asked to rate the difficulty of your breathing and the tiredness in you legs.
In response to this, you will turn the knob until the illumination reaches the point you think corresponds to how you 
are feeling. 0% equals no sensation, and 100% equals very severe sensation.
Finally, you will not be able to consume any alcohol 48 hours prior to each lab visit. You will be excluded from 
participating in this study if you take drugs (recreational or performance-enhancing drugs).
What are the side effects of taking part? There are none.
IWhat are the possible disadvantages and risks of taking part? Exercise has a negligible risk in healthy adults, 
although maximal exercise does carry a small risk o f inducing myocardial ischaemia (“heart attack”). The primary 
symptom of myocardial ischaemia is chest pain on exertion. If you experience any unusual sensations in your chest 
during the experiment, you should cease exercising immediately. Your heart rate will be monitored via adhesive 
electrodes placed at points on the chest (an "electrocardiogram" or EGG). In the unlikely event you experience 
serious problems during the exercise, medically-qualified personnel are on call at all times during the test and 
approved emergency procedures are in place.
At the end of the tests you will be very tired (exhausted), your legs will be very heavy and you will be out of breath.
It is also not uncommon to feel a little light-headed and sometimes nauseous. As the “constant-load” tests will last 
approximately 1 hour in total, it is possible that you may feel some discomfort after sitting on the bike for this long 
period.
You may experience difficulty swallowing while breathing through a mouthpiece and wearing a noseclip; this is due 
to a slight but transient pressure build up in your ears. Also, some subjects experience increased salivation while 
breathing through a mouthpiece.
When the catheter is removed from the back of the hand, a little bmising may occur. A small wound may also be 
evident. This may take a few days to heal.
When a muscle biopsy is taken, there is a small risk of inducing local pain, bmismg, infection or damage to adjacent 
tissue These may take a few days to subside. In the event of any problem being experienced after the muscle biopsy, 
we recommend that you seek medical advice by either contacting your GP or Professor Wilhelmina Behan (0141-211- 
2206) who took the biopsy. You should also notify Professor Susan Ward (0141-330-6287), the senior principal 
investigator, that a problem has occurred for which you have sought medical assistance.
What are the possible benefits of taking part? The results from the exercise tests will give you a good idea of 
how fit you are. The research team will take the time to explain these results to you. The information firom these 
tests will provide us with valuable information on the effect of muscle protein function on exercise performance.
What if something goes wrong? If you are harmed by taking part in this research project, there are no 
compensation arrangements. If you are harmed due to someone's negligence, then you may have grounds for a legal 
action but you may have to pay for it. The principal investigators, although not medically qualified, are fully trained
3 k ______________
in Advanced Life Support. In the event of an untoward incident, the principal investigator(s) will provide basic life 
support including chest compressions and ventilation, and will apply an advisory defibrillator (if necessary) until 
emergency medical staff are on hand.
If you are worried about any unwanted side effects from any of the above procedures, you should contact:
Professor Susan A Ward, Director
Director, Centre for Exercise Science and Medicine
Institute of Biomedical and Life Sciences
West Medical Building
University of Glasgow,
Glasgow G12 8QQ 
Phone: 0141 330 6287 
Fax: 0141 330 6345
e-mail: S.A.Ward@bio.gla.ac.uk
Will my taking part in this study be kept confidential? All information which is collected about you during the 
course of the research will be kept strictly confidential.
What will happen to the results of the research study? Results will be published in a peer-reviewed scientific 
journal once the study is completed. You will automatically be sent a copy of the full publication. You will not be 
identified in any publication.
I
Influence of creatine kinase and m itochondrial uncoupling proteins on the control of muscle oxygen 
consumption during exercise in healthy hum an subjects (Approved: O ctober 30, 2002; Revised Approval: 
January  06,2003 )
Consent Form
I....................... ....................................................................... ......................................
give my consent to the research procedures which are outlined above, the aim, procedures 
and possible consequences of which have been outlined to me
Signature .............................................................
Date................ ..........................................................
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CENTRE FOR EXERCISE SCIENCE AND MEDICINE
MEDICAL HISTORY
(CONFIDENTIAL)
Please read.
It is important to take a record of your medical history. You may 
have, or may have once had a condition that would make this type of 
testing unsuitable for you. For this reason we ask you to be as 
truthful and detailed as possible. At no point will this information be 
made available to any one other than the principal investigators for 
this study. If you have any doubts or questions, please ask.
SUBJECT DETAILS:
NAME:
AGE: D.O.B:
SEX (M/F):
GP NAME & ADDRESS:
SMOKING:
Never Smoked 
Not for >6 months , 
Smoke <10 per day 
Smoke >10 per day
ILLNESSES:
ALLERGIES:
HOSPITALISATIONS:
MUSCULO-SKELETAL DISORDER:
(Arthritis, Joint Pain, Fractures, Sports injury, Others)
CARDIOVASCULAR DISORDER: (Fever, Heart Munnurs, Chest Pain, Palpitations, High Blood 
Pressure, Others)
RESPIRATORY DISORDER: (Asthma, SOB, Cough, URTI, Others)
GASTROINTESTINAL DISORDER: (Jaundice, Bleeding, Others)
DIABETES:
iCNS DISORDER: (Fits, Blackouts, Tremor, Paralysis, Epilepsy, Other)
PSYCHIATRIC TREATMENT:
FAMILY HISTORY : (Sudden death in a first degree relative under the age of 35 years)
ARE YOU CURRENTLY TAKING ANY MEDICATION? No / Yes*
(*Please specify)____________________________________________________
ARE YOU CURRENTLY TAKING ANY SUBSTANCES TO HELP IMPROVE YOUR TRAINING 
OR CONTROL YOUR WEIGHT i.e. CREATINE, PROTEIN SUPPLEMENT? No / Yes*
(*Please specify)
ARE YOU CURRENTLY TAKING ANY OTHER SUPPLEMENTS i.e. FOOD SUPPLEMENTS, 
VITAMINS? N o/Y es*
(*Please specify)__________________________________________________________________________
CAN YOU THINK OF ANY OTHER REASON WHY YOU SHOULD NOT TAKE PART IN ANY OF 
OUR TESTS?
SYMPTOMS:
Do you experience any of the following, particularly on exercise?
Breathlessness No / Yes
Chest Pain No / Yes
Dizzy Fits/Fainting No / Yes '
Palpitations No / Yes
Please note that if you feel unwell on the day of the proposed test, or have been feeling poorly over 
the preceding day or two, please inform the investigators and DO NOT TAKE PART in the 
exercise test.
DECLARATION:
I have completed this questionnaire fully and truthfully. I have not kept any infonnation from the 
investigators that may put myself at risk during high-intensity exercise, or affect the results that they 
obtain. I understand that I may withdraw from any one test or the study as a whole if  I feel unwell, or feel 
uncomfortable with any part of the testing procedure.
(Signature).................
(Date)
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PHYSICAL EXAM:
WEIGHT:
PULSE (Resting):
HEIGHT:
BP (Resting):
Screened by: 
(Signature) . (Date)
IV
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